Endocrinology and Metabolism

Review Articles

Diabetes, obesity and metabolism
Glucocorticoid-Induced Hyperglycemia: A Neglected Problem: Jung-Hwan Cho, Sunghwan Suh; Endocrinol Metab. 2024;39(2):222-238. Published online March 27, 2024; DOI: https://doi.org/10.3803/EnM.2024.1951

48,810 View
1,492 Download
28 Web of Science
33 Crossref

Glucocorticoids provide a potent therapeutic response and are widely used to treat a variety of diseases, including coronavirus disease 2019 (COVID-19) infection. However, the issue of glucocorticoid-induced hyperglycemia (GIH), which is observed in over one-third of patients treated with glucocorticoids, is often neglected. To improve the clinical course and prognosis of diseases that necessitate glucocorticoid therapy, proper management of GIH is essential. The key pathophysiology of GIH includes systemic insulin resistance, which exacerbates hepatic steatosis and visceral obesity, as well as proteolysis and lipolysis of muscle and adipose tissue, coupled with β-cell dysfunction. For patients on glucocorticoid therapy, risk stratification should be conducted through a detailed baseline evaluation, and frequent glucose monitoring is recommended to detect the onset of GIH, particularly in high-risk individuals. Patients with confirmed GIH who require treatment should follow an insulin-centered regimen that varies depending on whether they are inpatients or outpatients, as well as the type and dosage of glucocorticoid used. The ideal strategy to maintain normoglycemia while preventing hypoglycemia is to combine basal-bolus insulin and correction doses with a continuous glucose monitoring system. This review focuses on the current understanding and latest evidence concerning GIH, incorporating insights gained from the COVID-19 pandemic.

Citations

Citations to this article as recorded by

Sepsis-associated encephalopathy: Unraveling molecular mechanisms, emerging therapeutics, and translational frontiers
Xinlong Zhang, Kaizong Huang, Zixin Wu, Rui Ding, Junming Han, Yuan Zhang, Yaping Lu, Yingmei Lu, Yanna Si
Pharmacology & Therapeutics.2026; 278: 108971. CrossRef
Nutritional modulation of biochemical pathways in stress response: A comprehensive review
Sandra Ajiroghene Gometi, Daniel Oghenerurie Ikpahwore, Uduenevwo Francis Evuen, Mercy Ogheneruno Omo-Okoroh, Ejohwomu Joe Otovbo, Prosper Chinyelum Okwuenu, Abigail Okezi Isoje, Iruoghene Onosakponome
Food and Humanity.2026; 6: 101017. CrossRef
Insulin Resistance in Systemic Sclerosis: Decoding Its Association with Severe Clinical Phenotype
Eugenio Capparelli, Luca Clerici, Giusy Cinzia Moltisanti, Francesco Lapia, Eleonora Zaccara, Francesca Capelli, Daniela Bompane, Maria Sole Chimenti, Sergio Finazzi, Paola Maria Luigia Faggioli, Antonino Mazzone
Journal of Clinical Medicine.2026; 15(2): 774. CrossRef
Increased incidence of diabetes mellitus in hematological malignancies: a systematic review and meta-analysis
Zahra Moradi, Samaneh Toutounchian, Anahita Akhiani, Hannaneh Razaghi, Mohammad Ali Mamdooh, Parmida Bagheri, Maryam Barkhordar, Zahra Salehi
BMC Cancer.2026;[Epub] CrossRef
Synergistic Efficacy of Lactobacillus plantarum Supernatant-Preconditioned BM-MSCs in Alleviating Depression, Anxiety-Like Behavior, and Memory Impairment in a Rat Stress Model by Suppressing the NF-κB Pathway
Mohammad Amini, Elahe Motevaseli, Maryam Zahmatkesh, Zahra Yousefi, Elham Esmaeil-Jamaat, Gholamreza Hassanzadeh, Tahmineh Mokhtari
Molecular Neurobiology.2026;[Epub] CrossRef
Pathogenic analysis of post-transplantation obesity: A comprehensive systematic review
Ke-Ran Chen, Lin-Zhi Wu, Yi-Ning Huang, Si-Yu Zhuang, Ze-Yu Chen, Bin Xu, Tian-Cheng Xu
World Journal of Transplantation.2026;[Epub] CrossRef
Glucocorticoid-Induced Hyperglycemia in Patients with Cancer: Mechanisms, Clinical Implications, and Management Strategies
Luana Lury Morikawa, Marcia Nery, Marcos Tadashi Kakitani Toyoshima
Endocrine Practice.2026;[Epub] CrossRef
Quercetin inhibits steroid-induced hypergluconeogenesis in Saccharomyces cerevisiae
Victor Arokia Doss, Gowtham Subramaniam, Keerthana Manoharan
Future Journal of Pharmaceutical Sciences.2025;[Epub] CrossRef
Complications related to oral corticosteroid use in asthma patients: a retrospective cohort study
Chih-Cheng Lai, Chao-Hsien Chen, Ya-Hui Wang, Cheng-Yi Wang, Hao-Chien Wang
Expert Review of Clinical Pharmacology.2025; 18(4): 225. CrossRef
The presumable combined effects of hydroxychloroquine and its metabolites on the blood lipids and glucose in the treatment of rheumatoid arthritis
Huaixuan Zhang, Xueting Wu, Yue Wang, Zhongling Yang, Yaqian Dai, Zongwen Shuai
Inflammopharmacology.2025; 33(5): 2769. CrossRef
Inhalable multilevel responsive microspheres for radiation-induced lung injury
Xinlian Wang, Jinhui Lin, Dongtao Yin, Xin Li, Zhichen Lang, Guanghui Zhang, Yueguang Xue, Shilin Li, Xiao Zhang, Bing Han, Fengsheng Li, Ying Liu
Nano Research.2025; 18(5): 94907339. CrossRef
Add-On Treatment with Gliclazide for Cancer Patients with Type 2 Diabetes Undergoing Cyclic Glucocorticoid-Containing Chemotherapy
Seung Eun Lee, Ju-Hyun Park, Dalyong Kim, Hyun-A Lee, Yun Seong Kang, Young Soon Yoon, Yun Jeong Jeong, Han Seok Choi, Kyoung-Ah Kim
Biomedicines.2025; 13(5): 1101. CrossRef
Bioengineered platelet nanoplatform enables renal-targeted dexamethasone delivery for chronic nephritis therapy with dual anti-inflammatory/anti-fibrotic effects and minimized systemic toxicity
Lingling Zhang, Haifeng Gong, Xuelian Gong, Bing Zhou, Xijian Wang, Shengnan Fei, Donglin Xia, Chunyang Xu, Xinzhong Huang
Bioactive Materials.2025; 52: 213. CrossRef
Continuous glucose monitoring to characterize hyperglycemia during chemotherapy for early stage breast cancer
Sophie R. Ulene, Shikun Wang, Joshua R. Cook, Fiona McAuley, Margaux E. Wooster, Khadija F. Faheem, Andrew Varoli, Julia E. McGuinness, Neil Vasan, Meghna S. Trivedi, Katherine D. Crew, Erik Harden, Cynthia Law, Dawn L. Hershman, Melissa K. Accordino
Breast Cancer Research and Treatment.2025; 212(3): 511. CrossRef
Lipid Hormones at the Intersection of Metabolic Imbalances and Endocrine Disorders
Maria-Zinaida Dobre, Bogdana Virgolici, Ruxandra Cioarcă-Nedelcu
Current Issues in Molecular Biology.2025; 47(7): 565. CrossRef
Dapagliflozin prevents glucocorticoid‐induced hyperglycaemia: Results from the DAPACOID Phase II Clinical Trial
Erick Josefat Díaz Huerta, German Duarte Bojórquez, Citlali Guadalupe Hernández Guzmán, Oscar Noel Chávez Hernández, Claudia Zepeda Moreno, Verónica Edith Velázquez Díaz, Eréndira Pacheco Zavala, Benjamín Sandoval Pérez, Alejandra Alvarez Salinas, Lauro F
Diabetes, Obesity and Metabolism.2025; 27(10): 6050. CrossRef
New-onset diabetes mellitus post COVID-19 infection: a systematic review and meta-analysis
Emma Cocking, Joseph Daher, Majid Alabbood
Diabetes Research and Clinical Practice.2025; 227: 112417. CrossRef
Managing Adverse Effects Associated with Long-Term Glucocorticoid Use
Mi Kyung Kim
The Korean Journal of Medicine.2025; 100(4): 158. CrossRef
Long-Term Neuroimaging Findings in a Murine Model of Human Extraparenchymal Neurocysticercosis
Alejandro Méndez, Agnes Fleury, Roger Carrillo-Mezo, Juan A. Hernández-Aceves, Montserrat Mejía-Hernández, Nelly Villalobos, Marisela Hernández, Raúl Bobes, Luis Concha, Juan J. Ortiz-Retana, Marta Romano, Pedro Tadao Hamamoto Filho, Gladis Fragoso, José
ACS Infectious Diseases.2025; 11(9): 2534. CrossRef
Impact of long-acting glucocorticoids on ICU mortality in septic patients with acute respiratory failure: a MIMIC-IV based cohort study
Yanhui Deng, Shaoxiang Wang, Shaohua Zhou, Wan Zhao, Aitian Wang, Jingli Gao
Frontiers in Pharmacology.2025;[Epub] CrossRef
The impact of diabetes and obesity on the severity and mortality of SARS-CoV-2 infection
Tomasz Klaudel, Michał Pelczarski, Monika Zaborska, Jakub Sadowski, Samanta Anna Ostrowska, Adam Drzymała, Rafał Jakub Bułdak
Journal of Diabetes & Metabolic Disorders.2025;[Epub] CrossRef
Emerging applications of nanotechnology in the treatment of acute kidney injury
Lingxue Zeng, Jonghan Kim, Hak Soo Choi, Michael P. Hutchens
Nanomedicine.2025; 20(21): 2661. CrossRef
Distinct microbial and metabolic shifts characterize acute coronary syndrome and recovery
Jing Xu, Die Dai, Yanan Yang, Shanshan Gao, Jingang Yang, Chaoran Dong, Weixian Yang, Jiansong Yuan, Tianjie Wang, Tao Tian, Yanmin Yang, Fang Luo, Ping Jiang, Chao Wu, Xiaolu Sun, Yonggang Sui, Guofeng Gao, Wentao Ma, Yuan Wu, Jun Zhang, Jia Li, Chao Guo
iMeta.2025;[Epub] CrossRef
The importance of glycemic status in burn patients’ outcomes
Haniyeh Sadat Fayazi
Burns.2025; 51(9): 107716. CrossRef
PROTOCOL: New‐Onset Diabetes Mellitus Post COVID‐19 Infection: A Systematic Review and Meta‐Analysis
Emma Cocking, Joseph Daher, Majid Alabbood
Campbell Systematic Reviews.2025;[Epub] CrossRef
The impact of the COVID-19 pandemic on the global burden of type 2 diabetes: a study based on GBD 2021 data
Xiaoqin Chen, Hui Lin, Yinlian Wu, Mingfang Wang, Su Lin, Jiaofeng Huang
Frontiers in Endocrinology.2025;[Epub] CrossRef
Balancing benefit and risk: clinical considerations in the use of acetaminophen, non-steroidal anti-inflammatory drugs, and dexamethasone for perioperative multimodal analgesia
Boohwi Hong, Woosuk Chung, Chahyun Oh
The Korean Journal of Pain.2025; 38(4): 364. CrossRef
Advances in anthocyanin nanoparticle delivery systems in anti-inflammatory therapies
Hanchi Zhang, Xinrui Qi, Lin Yang, Panpan Xia, Jitao Ling, Xuehong Zheng, Jianqi Liang, Pingping Yang, Yixuan Chen, Xiao Liu, Deju Zhang, Yaqi Rong, Caiwei Chen, Jing Zhang, Peng Yu, Yiming Gan
Pharmacological Research.2025; 222: 108038. CrossRef
Thyrotoxic Hypokalemic Periodic Paralysis: Pathophysiological Mechanisms
Gan Qing, Wan Nur Amalina Zakaria, Fatimah Zahra Mohamad Rom, Wan Nor Fazila Hafizan Wan Nik, Hani Ajrina Zulkeflee, Siti Nadirah Ab Rahim
Endocrinology and Metabolism.2025; 40(6): 821. CrossRef
Steroid-Induced Hyperglycaemia in a Patient With Possible Body Dissatisfaction: A Case Report
Chukwuebuka E Ohakpougwu, Wendy M Bebobru, Emmanuel Labram
Cureus.2025;[Epub] CrossRef
Cigarette Smoking-Induced Glucose Metabolic Reprogramming in Chronic Obstructive Pulmonary Disease: Mechanisms and Therapeutic Implications
Tingfen Ji, Yang-Yang Gu, Ying-Man Gao, Ying Xie, Zhao Liu, Anqi Cheng, Xinmei Zhou, Aihemaiti Ailifeire, Min Wang, Qingqing Song, Yuxin Shi, Shunyi Shi, Jiahui He, Liang Zhao, Dan Xiao, Chen Wang
International Journal of Chronic Obstructive Pulmonary Disease.2025; Volume 20: 3855. CrossRef
Effect of hypoglycemic events on cognitive function in individuals with type 2 diabetes mellitus: a dose–response meta-analysis
Min Ye, Qiqi Yang, Lele Zhang, Hudie Song, Qin Fu, Jun Qian, Hongyu Xie, Aihong Yuan
Frontiers in Neurology.2024;[Epub] CrossRef
Diabetes and the associated complications: The role of antioxidants in diabetes therapy and care
Lowell Dilworth, Dewayne Stennett, Aldeam Facey, Felix Omoruyi, Shada Mohansingh, Felix O. Omoruyi
Biomedicine & Pharmacotherapy.2024; 181: 117641. CrossRef

Adrenal gland
A Contemporary Approach to the Diagnosis and Management of Adrenal Insufficiency: Suranut Charoensri, Richard J. Auchus; Endocrinol Metab. 2024;39(1):73-82. Published online January 22, 2024; DOI: https://doi.org/10.3803/EnM.2024.1894

26,292 View
1,903 Download
8 Web of Science
13 Crossref

Abstract PDF PubReader ePub

Adrenal insufficiency (AI) can be classified into three distinct categories based on its underlying causes: primary adrenal disorders, secondary deficiencies in adrenocorticotropin, or hypothalamic suppression from external factors, most commonly glucocorticoid medications used for anti-inflammatory therapy. The hallmark clinical features of AI include fatigue, appetite loss, unintentional weight loss, low blood pressure, and hyponatremia. Individuals with primary AI additionally manifest skin hyperpigmentation, hyperkalemia, and salt craving. The diagnosis of AI is frequently delayed due to the non-specific symptoms and signs early in the disease course, which poses a significant challenge to its early detection prior to an adrenal crisis. Despite the widespread availability of lifesaving glucocorticoid medications for decades, notable challenges persist, particularly in the domains of timely diagnosis while simultaneously avoiding misdiagnosis, patient education for averting adrenal crises, and the determination of optimal replacement therapies. This article reviews recent advancements in the contemporary diagnostic strategy and approaches to optimal treatment for AI.

Citations

Citations to this article as recorded by

Adrenal insufficiency in severely wounded men with combat gunshot injury
N.Yu. Seliukova, K.V. Misiura, E.M. Khoroshun, V.V. Makarov, V.V. Nehoduiko, O.I. Zalyubovska, E. Szucsik
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2025; 20(8): 573. CrossRef
A deep learning algorithm for automated adrenal gland segmentation on non-contrast CT images
Fanxing Meng, Tuo Zhang, Yukun Pan, Xiaojing Kan, Yuwei Xia, Mengyuan Xu, Jin Cai, Fangbin Liu, Yinghui Ge
BMC Medical Imaging.2025;[Epub] CrossRef
Metabolic and endocrine dysfunctions in traumatic brain injury: Implications for cognitive recovery and therapeutic strategies
Jigar Manilal Haria, Naveen Kumar Singh, Jayballabh Kumar, Sanjeev Kumar Jain, DattaSai Pamidimarri
Behavioural Brain Research.2025; 493: 115697. CrossRef
Recurrent Hyponatremia Mimicking Syndrome of Inappropriate Antidiuretic Hormone Secretion: A Case of Partial Empty Sella Syndrome With Isolated Adrenocorticotropic Hormone Deficiency
Revathi Rajendran, Amirthalingeswaran Govindan
Cureus.2025;[Epub] CrossRef
Management of Primary Adrenal Insufficiency and Overt Hypothyroidism in an HIV‐Positive Patient in a Resource‐Limited Setting: A Case Report
Majani Edward, Witness John, Dominick M. Raphael
Clinical Case Reports.2025;[Epub] CrossRef
A practical approach to diagnosis and treatment in children with primary adrenal insufficiency
Donatella Capalbo, Sara Illiano, Sara Vasaturo, Paola Lorello, Francesca Romana Rotondo, Raffaella Di Mase, Carla Bizzarri, Mariacarolina Salerno
European Journal of Endocrinology.2025; 193(5): R45. CrossRef
The Effect of Whitening Creams Usage on the Adrenal Gland 
Fadheelah Salman Azeez, Noor Faisal Noaman, Ahmed Neema AL-Mussawy
F1000Research.2025; 14: 1434. CrossRef
Unintentional discontinuation of topical corticosteroids after emergency hospitalization can exacerbate adrenal insufficiency
Hiroya Kitsunai, Yumika Watanabe, Eisuke Nishikawa, Fumika Maruyama, Hiroshi Nomoto
Endocrine Journal.2025; 72(12): 1377. CrossRef
Diagnostic pharmacology: Drugs that uncover diseases
K. Saranraj, Gollapudi Poojitha Siri Chandana
National Journal of Pharmacology and Therapeutics.2025; 3(3): 197. CrossRef
Post-Traumatic Hypopituitarism
Nissa Blocher
Current Physical Medicine and Rehabilitation Reports.2024; 12(4): 405. CrossRef
Severe Fatigue in Uncontrolled Asthma: Contributing Factors and Impact of Rehabilitation
Karin B. Fieten, Lianne ten Have, Linde N. Nijhof, Lucia Rijssenbeek-Nouwens, Anneke ten Brinke
The Journal of Allergy and Clinical Immunology: In Practice.2024; 12(12): 3292. CrossRef
Adrenal Insufficiency in Patients with Beta Thalassemia: A Meta-Analysis
Christos Savvidis, Dimitra Ragia, Sophia Delicou, Aikaterini Xydaki, Manfredi Rizzo, Ioannis Ilias
Medicina.2024; 60(10): 1571. CrossRef
長期間の呼吸管理および遷延する低血圧から診断に至ったACTH単独欠損症の1例(A case of isolated ACTH deficiency diagnosed after long–term respiratory management and persistent hypotension)
古谷慎太郎, 神山治郎, 多喜亘, 山本大輔, 五木田昌士, 田口茂正, 清田和也
Nihon Kyukyu Igakukai Zasshi: Journal of Japanese Association for Acute Medicine.2024; 35(12): 965. CrossRef

Original Article

Adrenal gland Big Data Articles (National Health Insurance Service Database)
Mortality and Severity of Coronavirus Disease 2019 in Patients with Long-Term Glucocorticoid Therapy: A Korean Nationwide Cohort Study: Eu Jeong Ku, Keeho Song, Kyoung Min Kim, Gi Hyeon Seo, Soon Jib Yoo; Endocrinol Metab. 2023;38(2):253-259. Published online March 21, 2023; DOI: https://doi.org/10.3803/EnM.2022.1607

6,582 View
127 Download
5 Web of Science
5 Crossref

Abstract PDF PubReader ePub

Background
The severity of coronavirus disease 2019 (COVID-19) among patients with long-term glucocorticoid treatment (LTGT) has not been established. We aimed to evaluate the association between LTGT and COVID-19 prognosis.
Methods
A Korean nationwide cohort database of COVID-19 patients between January 2019 and September 2021 was used. LTGT was defined as exposure to at least 150 mg of prednisolone (≥5 mg/day and ≥30 days) or equivalent glucocorticoids 180 days before COVID-19 infection. The outcome measurements were mortality, hospitalization, intensive care unit (ICU) admission, length of stay, and mechanical ventilation.
Results
Among confirmed patients with COVID-19, the LTGT group (n=12,794) was older and had a higher proportion of comorbidities than the control (n=359,013). The LTGT group showed higher in-hospital, 30-day, and 90-day mortality rates than the control (14.0% vs. 2.3%, 5.9% vs. 1.1%, and 9.9% vs. 1.8%, respectively; all P<0.001). Except for the hospitalization rate, the length of stay, ICU admission, and mechanical ventilation proportions were significantly higher in the LTGT group than in the control (all P<0.001). Overall mortality was higher in the LTGT group than in the control group, and the significance remained in the fully adjusted model (odds ratio [OR], 5.75; 95% confidence interval [CI], 5.31 to 6.23) (adjusted OR, 1.82; 95% CI, 1.67 to 2.00). The LTGT group showed a higher mortality rate than the control within the same comorbidity score category.
Conclusion
Long-term exposure to glucocorticoids increased the mortality and severity of COVID-19. Prevention and early proactive measures are inevitable in the high-risk LTGT group with many comorbidities.

Citations

Citations to this article as recorded by

Hormonal Implications of SARS‐CoV‐2: A Review of Endocrine Disruptions
Aliya Yskak, Yevgeniy Sokharev, Kuanysh Zhumalynov, Elizaveta Koneva, Natalia Afanasyeva, Dmitri Borodulin, Dmitrii Babaskin, Almabek Nugmanov, Murat Nurushev, Vadim Chashkov, Gianmarco Ferrara
Scientifica.2025;[Epub] CrossRef
Association Between Pre-hospital Medication Use and Outcomes in Patients Hospitalized for COVID-19 Pneumonia: A Multicenter Observational Study in the Netherlands
Letao Li, Joyce Goris-de Geus, Iris de Leeuw, Floortje Kanits, Jaccoline Zegers, Arjan van Zadelhoff, Noud Buenen, Thijs Clemens David Rettig, Monique P. L Hoir, Geerke Duijzer, Johanna Marianne Geleijnse, Henrik Endeman
Cureus.2025;[Epub] CrossRef
Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study
Almudena Rodríguez-Fernández, Irene Visos-Varela, Maruxa Zapata-Cachafeiro, Samuel Pintos-Rodríguez, Rosa M. García-Álvarez, Teresa M. Herdeiro, María Piñeiro-Lamas, Adolfo Figueiras, Ángel Salgado-Barreira, Rosendo Bugarín-González, Eduardo Carracedo-Mar
Inflammopharmacology.2024; 32(4): 2305. CrossRef
Glucocorticoids as a Double-Edged Sword in the Treatment of COVID-19: Mortality and Severity of COVID-19 in Patients Receiving Long-Term Glucocorticoid Therapy
Eun-Hee Cho
Endocrinology and Metabolism.2023; 38(2): 223. CrossRef
Pituitary Diseases and COVID-19 Outcomes in South Korea: A Nationwide Cohort Study
Jeonghoon Ha, Kyoung Min Kim, Dong-Jun Lim, Keeho Song, Gi Hyeon Seo
Journal of Clinical Medicine.2023; 12(14): 4799. CrossRef

Review Articles

Diabetes, Obesity and Metabolism
Effects of Intermittent Fasting on the Circulating Levels and Circadian Rhythms of Hormones: Bo Hye Kim, Yena Joo, Min-Seon Kim, Han Kyoung Choe, Qingchun Tong, Obin Kwon; Endocrinol Metab. 2021;36(4):745-756. Published online August 27, 2021; DOI: https://doi.org/10.3803/EnM.2021.405

111,574 View
1,574 Download
66 Web of Science
70 Crossref

Abstract PDF PubReader ePub

Intermittent fasting has become an increasingly popular strategy in losing weight and associated reduction in obesity-related medical complications. Overwhelming studies support metabolic improvements from intermittent fasting in blood glucose levels, cardiac and brain function, and other health benefits, in addition to weight loss. However, concerns have also been raised on side effects including muscle loss, ketosis, and electrolyte imbalance. Of particular concern, the effect of intermittent fasting on hormonal circadian rhythms has received little attention. Given the known importance of circadian hormonal changes to normal physiology, potential detrimental effects by dysregulation of hormonal changes deserve careful discussions. In this review, we describe the changes in circadian rhythms of hormones caused by intermittent fasting. We covered major hormones commonly pathophysiologically involved in clinical endocrinology, including insulin, thyroid hormones, and glucocorticoids. Given that intermittent fasting could alter both the level and frequency of hormone secretion, decisions on practicing intermittent fasting should take more considerations on potential detrimental consequences versus beneficial effects pertaining to individual health conditions.

Citations

Citations to this article as recorded by

Intermittent fasting as a dietary intervention with potential sexually dimorphic health benefits
Julia Rius-Bonet, Salvador Macip, Daniel Closa, Marta Massip-Salcedo
Nutrition Reviews.2025; 83(2): e635. CrossRef
Intermittent fasting triggers interorgan communication to suppress hair follicle regeneration
Han Chen, Chao Liu, Shiyao Cui, Yingqian Xia, Ke Zhang, Hanxiao Cheng, Jingyu Peng, Xiaoling Yu, Luyang Li, Hualin Yu, Jufang Zhang, Ju-Sheng Zheng, Bing Zhang
Cell.2025; 188(1): 157. CrossRef
A multicenter mixed-methods study on the effects of intermittent fasting in patients with immune thrombocytopenia receiving thrombopoietin receptor agonists
Mohamed A. Yassin, Muna AlRasheed, Taghreed Al-Eisa, Noura Alhashim, Fiasal Alsayegh, Tarek E. Abouzeid, Mohamed Abd El Fattah, Maryam Alfili, Neveen Shalaby, Abdullah Alotaibi, Nourah Aljuwaisri, Anwar Almasbahi, Rii Saleeb, Hend Abdelaziz, Awni Alshuraf
Frontiers in Nutrition.2025;[Epub] CrossRef
Alternate-day fasting differentially affects body composition, metabolic and immune response to fasting in male rats exposed to early-life adversity: Modulatory role of cafeteria diet
Sara C. Sagae, Edson D. R. Paz, Bárbara Zanardini, Ana Claudia Amaral, Gabriela A. Bronczek, Patrícia Koehler-Santos, Jarbas R. de Oliveira, Celso R. Franci, Márcio V. F. Donadio, Parker J. Holman, Charlis Raineki, Patrick Goymer
PLOS ONE.2025; 20(3): e0313103. CrossRef
Evaluation of the effectiveness of intermittent fasting versus caloric restriction in weight loss and improving cardiometabolic health: A systematic review and meta-analysis
Samah O. Alfahl
Journal of Taibah University Medical Sciences.2025; 20(2): 159. CrossRef
Chrononutrition, diet quality and perceived stress: results from two population-based studies in Brazil
Micaela Rabelo Quadra, Antônio Augusto Schäfer, Leonardo Pozza Santos, Luana Meller Manosso, Tamara Justin da Silva, Elisabete Borges Maciel, Fernanda Oliveira Meller
Ciência & Saúde Coletiva.2025;[Epub] CrossRef
Effects of intermittent fasting diet in overweight and obese postmenopausal women with rheumatoid arthritis: A randomized controlled clinical trial
Mahsa Ranjbar, Sakineh Shab-Bidar, Abdolrahman Rostamian, Hamed Mohammadi, Aryan Tavakoli, Kurosh Djafarian
Complementary Therapies in Medicine.2025; 91: 103189. CrossRef
Residence of mice in metabolic cages reduces experimental kidney inflammation through stress-induced glucocorticoids
Junping Yin, Melanie Eichler, Clivia Lisowski, Jian Li, Sibylle von Vietinghoff, Natalio Garbi, Qi Mei, Anne-Kathrin Gellner, Christian Kurts
JCI Insight.2025;[Epub] CrossRef
Impact of intermittent fasting on physical activity: a national survey of Chinese residents aged 18–80 years
Feiying He, Shiyu Bai, Xiangchun Xu, Jingqiao Miao, Hongwen Yu, Jiale Qiu, Yibo Wu, Yangdong Fan, Lei Shi
Frontiers in Physiology.2025;[Epub] CrossRef
A Narrative Review about Metabolic Pathways, Molecular Mechanisms and Clinical Implications of Intermittent Fasting as Autophagy Promotor
Álvaro Andrés Vergara Nieto, Andrés Halabi Diaz, Millaray Hernández, Daniel Sagredo
Current Nutrition Reports.2025;[Epub] CrossRef
A Comprehensive Perspective on the Biological Effects of Intermittent Fasting and Periodic Short-Term Fasting: A Promising Strategy for Optimizing Metabolic Health
Barbara Ciastek, Karolina Kapłon, Przemysław Domaszewski
Nutrients.2025; 17(13): 2061. CrossRef
The intersection of circadian rhythms and the blood-brain barrier with drug efficacy and delivery in neurological disorders
Kyra A. Schindler, Silvia Torices, Nicolette Schurhoff, Daniela Iglesias Gallo, Michal Toborek
Advanced Drug Delivery Reviews.2025; 224: 115645. CrossRef
Intermittent Fasting as a Neuroprotective Strategy: Gut–Brain Axis Modulation and Metabolic Reprogramming in Neurodegenerative Disorders
Zaw Myo Hein, Muhammad Faqhrul Fahmy Arbain, Suresh Kumar, Muhammad Zulfadli Mehat, Hafizah Abdul Hamid, Muhammad Danial Che Ramli, Che Mohd Nasril Che Mohd Nassir
Nutrients.2025; 17(14): 2266. CrossRef
Vital Role of Visceral Adipose Tissue in Maintaining Cognitive Functions
Rina Shirafuji, Yoko Amagase, Ai Goto, Yoshinori Takei
International Journal of Molecular Sciences.2025; 26(14): 6597. CrossRef
Intermittent Fasting and Hormonal Regulation: Pathways to Improved Metabolic Health
Wijdan Shkorfu, Abdulmannan Fadel, Mohammed Hamsho, Yazan Ranneh, Hafiz Muhammad Shahbaz
Food Science & Nutrition.2025;[Epub] CrossRef
Intermittent fasting: Evidence for benefit, lack of effect, or potential cardiometabolic risk?
Anoop Misra, Ritesh Gupta
Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2025; 19(7): 103280. CrossRef
Alternate-day fasting elicits larger changes in fat mass than time-restricted eating in adults without obesity – A randomized clinical trial
Nina Derron, Andreas T. Güntner, Ines C. Weber, Julia Braun, İlker Ö. Koska, Alaa Othman, Leonie Mönch, Arnold von Eckardstein, Milo A. Puhan, Felix Beuschlein, Michel Hochuli, Nicola Zamboni, Roman Guggenberger, Philipp A. Gerber
Clinical Nutrition.2025; 53: 212. CrossRef
Safety and effectiveness of apixaban use for stroke prevention during Ramadan fasting (the API-RAM study)
Aiman Ghrab, Rania Gargouri, Faouzi Addad, Anis Cheikhrouhou, Mariem Jabeur, Selma Charfeddine, Amine Bahloul, Zied Triki, Tarek Ellouze, Omar Abidi, Souad Mallek, Faten Triki, Salem Abdessalem, Ismail Elalamy, Leila Abid
Frontiers in Pharmacology.2025;[Epub] CrossRef
Intermittent fasting triggers interorgan communication to improve the progression of diabetic osteoporosis
Zhiyuan Guan, Wenyu Xiao, Zhiqiang Guan, Jin Xiao, Xuehan Jin, Shengfu Liu, Yin Qin, Liying Luo
Gut Microbes.2025;[Epub] CrossRef
Time-Restricted Eating, ANGPTL4, and Reduction in Residual Cardiovascular Risk
Alejandro Gugliucci
Journal of Clinical Medicine.2025; 14(19): 7026. CrossRef
What effect does fasting in Ramadan have on women's health? a review
Fatemeh Hosseini, Reyhaneh Hassanshahi
Payesh (Health Monitor) Journal.2025; 24(4): 525. CrossRef
Effects of Short-Term (20-Day) Alternate-Day Modified Fasting and Time-Restricted Feeding on Fasting Glucose and IGF-1 in Obese Young Women
Dian Aristia Rachmayanti, Purwo Sri Rejeki, Raden Argarini, Hermina Novida, Sri Soenarti, Shariff Halim, Chy’as Diuranil Astrid Permataputri, Sheeny Priska Purnomo
Diseases.2025; 13(12): 390. CrossRef
Controversies and Perspectives of Time-Qualified Dietary Interventions
Sofia Lotti, Silvia Gallosti, Ramona De Amicis, Simona Bertoli, Barbara Colombini, Gianluigi Mazzoccoli, Monica Dinu
Nutrients.2025; 17(24): 3894. CrossRef
Adipose Tissue Circadian Clocks: Implications for Metabolism and Metabolic Dysfunction
Peiyuan Zeng, Michael A. Hill, Jianbo Wu
Obesity Reviews.2025;[Epub] CrossRef
Endocrine Adaptations to Prolonged Fasting: From Physiology, Clinical Uncertainties, Translational Challenges to Healthspan Implications
Rok Herman, Jure Trsan, Luka Lipar, Mojca Jensterle, Andrej Janez
Nutrients.2025; 17(24): 3949. CrossRef
THE INTERPLAY BETWEEN DIET AND HORMONAL REGULATION: A NARRATIVE REVIEW
Ewa Jagodzińska, Zuzanna Jabłońska, Maja Jabłońska, Julia Kamińska, Joanna Zygadło, Wiktor Milewczyk
International Journal of Innovative Technologies in Social Science.2025;[Epub] CrossRef
INTERMITTENT FASTING: LITERATURE REVIEW WITH BIBLIOMETRIC ANALYSIS
Hanna Hordiienko, Vitalii Sikora
Eastern Ukrainian Medical Journal.2025; 13(4): 941. CrossRef
Common and divergent molecular mechanisms of fasting and ketogenic diets
Antonio Paoli, Grant M. Tinsley, Mark P. Mattson, Immaculata De Vivo, Ravi Dhawan, Tatiana Moro
Trends in Endocrinology & Metabolism.2024; 35(2): 125. CrossRef
Identifying Acss1, Mtfp1 and Oxct1 as key regulators and promising biomarkers of sarcopenia in various models
Hailong Cui, Die Hu, Yanling Liu, Jiejie Zhao
Gene.2024; 896: 148053. CrossRef
Circadian Rhythms, Chrononutrition, Physical Training, and Redox Homeostasis—Molecular Mechanisms in Human Health
Cristina Manuela Drăgoi, Alina Crenguţa Nicolae, Anca Ungurianu, Denisa Marilena Margină, Daniela Grădinaru, Ion-Bogdan Dumitrescu
Cells.2024; 13(2): 138. CrossRef
Various types of fasting diet and possible benefits in nonalcoholic fatty liver: Mechanism of actions and literature update
Zahra Sadat Mirrazavi, Vahideh Behrouz
Clinical Nutrition.2024; 43(2): 519. CrossRef
Attention to Innate Circadian Rhythm and the Impact of Its Disruption on Diabetes
Da Young Lee, Inha Jung, So Young Park, Ji Hee Yu, Ji A Seo, Kyeong Jin Kim, Nam Hoon Kim, Hye Jin Yoo, Sin Gon Kim, Kyung Mook Choi, Sei Hyun Baik, Nan Hee Kim
Diabetes & Metabolism Journal.2024; 48(1): 37. CrossRef
Genetics of Exercise and Diet-Induced Fat Loss Efficiency: A Systematic Review
Aleksandra Bojarczuk, Emiliya S. Egorova, Magdalena Dzitkowska-Zabielska, Ildus I. Ahmetov
Journal of Sports Science and Medicine.2024; : 236. CrossRef
Ramadan fasting in the third trimester of pregnancy and postpartum colostrum cortisol concentrations in Morocco
Meagan M. Guilfoyle
American Journal of Human Biology.2024;[Epub] CrossRef
Dietary factors in circadian rhythm modulation and their impact on metabolic diseases: a state of the science review
Malvika Dalvi, Srujana Medithi
Biological Rhythm Research.2024; 55(3-4): 233. CrossRef
Unlocking the Benefits of Fasting: A Review of its Impact on Various Biological Systems and Human Health
Rawan Mackieh, Nadia Al-Bakkar, Milena Kfoury, Nathalie Okdeh, Hervé Pietra, Rabih Roufayel, Christian Legros, Ziad Fajloun, Jean-Marc Sabatier
Current Medicinal Chemistry.2024; 31(14): 1781. CrossRef
Chrono-Endocrinology in Clinical Practice: A Journey from Pathophysiological to Therapeutic Aspects
Silvia Mercadante, Antonio Bellastella
Life.2024; 14(5): 546. CrossRef
Pu‐erh tea reduces the transmission of CRD‐mediated alopecia risk to offspring
Shanshan Hu, Jie Wang, Zhiyuan Lin, Bowen Zhang, Liyong Luo, Liang Zeng
Food Frontiers.2024; 5(4): 1673. CrossRef
Effects of Early and Late Time-Restricted Feeding on Parameters of Metabolic Health: An Explorative Literature Assessment
Froso Petridi, Jan M. W. Geurts, Jean Nyakayiru, Anne Schaafsma, Dedmer Schaafsma, Ruth C. R. Meex, Cécile M. Singh-Povel
Nutrients.2024; 16(11): 1721. CrossRef
Ramadan intermittent fasting is associated with improved anticoagulant activity among healthy people: a case–control study
Abeer Khalid Al-Ghumlas
Scientific Reports.2024;[Epub] CrossRef
Adaptive Effects of Endocrine Hormones on Metabolism of Macronutrients during Fasting and Starvation: A Scoping Review
Reza Karimi, Alina Yanovich, Fawzy Elbarbry, Anita Cleven
Metabolites.2024; 14(6): 336. CrossRef
The effect of intermittent fasting on preventing obesity-related early aging from a molecular and cellular perspective
Nurma Yuliyanasari, Purwo Sri Rejeki, Hanik Badriyah Hidayati, Phawinee Subsomwong, Muhammad Miftahussurur
Journal of Medicine and Life.2024; 17(3): 261. CrossRef
Marital Status and Serum Level of Testosterone: In Relation to Serum Level of Cortisol
Rezanezhad Babak, Borgquist Rasmus, Elzanaty Saad
Archive of Urological Research.2024; 8(2): 018. CrossRef
Evaluating the efficacy of intermittent fasting and exercise combinations for weight loss: A network meta‐analysis
Xiaoyan Cheng, Shunli Sun, Maolin Chen, Xinyou Zhou, Mingxin Rao, Dongjuan Guo, Jinfeng Xie, Qiang Huang, Liqiang Su
Obesity Reviews.2024;[Epub] CrossRef
Effects of Intermittent Fasting on Female Reproductive Function: A Review of Animal and Human Studies
Lei Mao, Aixia Liu, Xiaohui Zhang
Current Nutrition Reports.2024; 13(4): 786. CrossRef
Impact of Modern Lifestyle on Circadian Health and Its Contribution to Adipogenesis and Cancer Risk
Oxana Dobrovinskaya, Javier Alamilla, Miguel Olivas-Aguirre
Cancers.2024; 16(21): 3706. CrossRef
Religious intermittent fasting: Effects on liver health, metabolic markers, and gut microbiota in type 2 diabetes patients
Svenja Sydor, Ender Engin, Samantha Wittek, Peter Lemmer, Jan Best, Martin Steinmetz, Anja Figge, Andreas Jähnert, Mustafa Özcürümez, Martina Broecker-Preuss, Wing-Kin Syn, Ali Canbay, Paul Manka
Clinical Nutrition Open Science.2024; 58: 370. CrossRef
Intermittent fasting: Effectiveness and safety. A review
Marina V. Altashina, Ekaterina V. Ivannikova, Ekaterina A. Troshina
Terapevticheskii arkhiv.2024; 96(10): 984. CrossRef
Examining Associations Between Fasting Behavior, Orthorexia Nervosa, and Eating Disorders
Przemysław Domaszewski, Aleksandra M. Rogowska, Kaja Żylak
Nutrients.2024; 16(24): 4275. CrossRef
Real-world effectiveness of glucose-guided eating using the Data-Driven Fasting app among adults interested in weight and glucose management: An observational study (Preprint)
Michelle R Jospe, Martin Kendall, Susan M Schembre, Melyssa Roy
JMIR Formative Research.2024;[Epub] CrossRef
Fasting intervention and its clinical effects on the human host and microbiome
Sofia K. Forslund
Journal of Internal Medicine.2023; 293(2): 166. CrossRef
Umbrella review of time-restricted eating on weight loss, fasting blood glucose, and lipid profile
Han Shi Jocelyn Chew, Wei How Darryl Ang, Zhen Yang Abel Tan, Wen Wei Ang, Kin Sun Chan, Ying Lau
Nutrition Reviews.2023; 81(9): 1180. CrossRef
Thermodynamic Assessment of the Effects of Intermittent Fasting and Fatty Liver Disease Diets on Longevity
Melek Ece Öngel, Cennet Yildiz, Özge Başer, Bayram Yilmaz, Mustafa Özilgen
Entropy.2023; 25(2): 227. CrossRef
Effects of Intermittent Fasting on Hypothalamus–Pituitary–Thyroid Axis, Palatable Food Intake, and Body Weight in Stressed Rats
Cinthia García-Luna, Ixchel Prieto, Paulina Soberanes-Chávez, Elena Alvarez-Salas, Iván Torre-Villalvazo, Gilberto Matamoros-Trejo, Patricia de Gortari
Nutrients.2023; 15(5): 1164. CrossRef
Possible homeostatic, glucose uptake mechanisms and hepato-pancreatic histological effects of intermittent fasting, exercise, starvation, and honey in streptozotocin-induced diabetes in rats
Ejime A. Chijiokwu, Eze K. Nwangwa, Mega O. Oyovwi, Benneth Ben-Azu, Alexander O. Naiho, Emuesiri Goodies Moke, Victor Emojevwe, Prosper A. Ehiwarior, Udoka S. Nwabuoku
Nutrire.2023;[Epub] CrossRef
Mid-Point of the Active Phase Is Better to Achieve the Natriuretic Effect of Acute Salt Load in Mice
Momoko Imamura, Hiroyuki Sasaki, Katsuki Hayashi, Shigenobu Shibata
Nutrients.2023; 15(7): 1679. CrossRef
All That Glitters Is Not Gold: The Same Sleep Time, but Different Diabetogenic Outcomes
Bohye Kim, Obin Kwon
Endocrinology and Metabolism.2023; 38(1): 78. CrossRef
The emerging role of circadian rhythms in the development and function of thermogenic fat
Xuemin Peng, Yong Chen
Frontiers in Endocrinology.2023;[Epub] CrossRef
Time-restricted Feeding Changes as Inspiration for Drug Design
Zhangyuting He, Huayu Yang, Yilei Mao
Current Pharmaceutical Design.2023; 29(8): 559. CrossRef
Brain Dopamine–Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects
Anthony H. Cincotta
International Journal of Molecular Sciences.2023; 24(17): 13255. CrossRef
Adaptive Circadian Rhythms for Autonomous and Biologically Inspired Robot Behavior
Marcos Maroto-Gómez, María Malfaz, Álvaro Castro-González, Sara Carrasco-Martínez, Miguel Ángel Salichs
Biomimetics.2023; 8(5): 413. CrossRef
Intermittent Fasting on Human Health and Disease
Denisa Marilena Margină, Cristina Manuela Drăgoi
Nutrients.2023; 15(21): 4491. CrossRef
Synthetic augmentation of bilirubin metabolism in human pluripotent stem cell-derived liver organoids
Hasan Al Reza, Zishaan Farooqui, Abid Al Reza, Callen Conroy, Kentaro Iwasawa, Yasuhiro Ogura, Keisuke Okita, Kenji Osafune, Takanori Takebe
Stem Cell Reports.2023; 18(11): 2071. CrossRef
Average phenotype but not plasticity in two metabolic hormones covary in wild female bonobos (Pan paniscus)
Ruth Sonnweber, Gottfried Hohmann, Jeroen M. G. Stevens, Tobias Deschner, Barbara Fruth, Anna-Lena Fiedler, Niina O. Nurmi, Verena Behringer
Frontiers in Ecology and Evolution.2023;[Epub] CrossRef
Intermittent fasting, high-intensity interval training, or a combination of both have beneficial effects in obese mice with nonalcoholic fatty liver disease
Patrícia de Castro-de-Paiva, Thatiany de Souza Marinho, Carlos Alberto Mandarim-de-Lacerda, Marcia Barbosa Aguila
The Journal of Nutritional Biochemistry.2022; 104: 108997. CrossRef
Optimal Timing of Thyroid Hormone Replacement During Ramadan Fasting: A Randomized Controlled Trial in Patients with Prior Total Thyroidectomy
Khalid M. Al-Qahtani, Ibraheem Ahmed Aldeeri, Amal M. Alshaibi, Norah Salman Alshabib, Rakan M. Barghouthi, Ebtihal Y. Alyusuf, Anwar Ali Jammah
Thyroid.2022; 32(9): 1029. CrossRef
Exploring the Effects of Energy Constraints on Performance, Body Composition, Endocrinological/Hematological Biomarkers, and Immune System among Athletes: An Overview of the Fasting State
Hadi Nobari, Saber Saedmocheshi, Eugenia Murawska-Ciałowicz, Filipe Manuel Clemente, Katsuhiko Suzuki, Ana Filipa Silva
Nutrients.2022; 14(15): 3197. CrossRef
Alternate day fasting and time-restricted feeding may confer similar neuroprotective effects during aging in male rats
Sukanya Bhoumik, Rashmi Kesherwani, Raushan Kumar, Syed Ibrahim Rizvi
Biogerontology.2022; 23(6): 757. CrossRef
Intermittent Fasting—A Healthy Dietary Pattern for Diabetic Nephropathy
Ming Yang, Wei Chen, Liyu He, Di Liu, Li Zhao, Xi Wang
Nutrients.2022; 14(19): 3995. CrossRef
β-hydroxybutyrate as an Anti-Aging Metabolite
Lian Wang, Peijie Chen, Weihua Xiao
Nutrients.2021; 13(10): 3420. CrossRef

Miscellanenous
Cushing Syndrome Associated Myopathy: It Is Time for a Change: Martin Reincke; Endocrinol Metab. 2021;36(3):564-571. Published online June 18, 2021; DOI: https://doi.org/10.3803/EnM.2021.1069

12,763 View
242 Download
19 Web of Science
19 Crossref

Abstract PDF PubReader ePub

Cushing syndrome is the result of excessive levels of glucocorticoids. Endogenous Cushing syndrome is rare with an incidence of two to three cases per million per year. Clinically, the presentation consists of a characteristic phenotype including skin symptoms and metabolic manifestations. A frequent co-morbidity with high impact on quality of life is Cushing syndrome associated myopathy. It characteristically affects the proximal myopathy, impairing stair climbing and straightening up. The pathophysiology is complex and involves protein degradation via the forkhead box O3 (FOXO3) pathway, intramuscular fat accumulation, and inactivity-associated muscle atrophy. Surgical remission of Cushing syndrome is the most important step for recovery of muscle function. Restoration depends on age, co-morbidities and postoperative insulin-like growth factor concentrations. At average, functionality remains impaired during the long-term compared to age and sex matched control persons. Growth hormone therapy in individuals with impaired growth hormone secretion could be an option but has not been proved in a randomized trial.

Citations

Citations to this article as recorded by

Osteosarcopenic adiposity and its relation to cancer and chronic diseases: Implications for research to delineate mechanisms and improve clinical outcomes
Jasminka Z. Ilich, Biljana Pokimica, Danijela Ristić-Medić, Snjezana Petrović, Aleksandra Arsić, Nadja Vasiljević, Vesna Vučić, Owen J. Kelly
Ageing Research Reviews.2025; 103: 102601. CrossRef
Glucocorticoid-Mediated Skeletal Muscle Atrophy: Molecular Mechanisms and Potential Therapeutic Targets
Uttapol Permpoon, Jiyeong Moon, Chul Young Kim, Tae-gyu Nam
International Journal of Molecular Sciences.2025; 26(15): 7616. CrossRef
Side effects and ineffectiveness of standard therapy for idiopathic recurrent pericarditis: status of the problem and description of clinical cases. Case report
Angelina A. Petrukhina, Alfia А. Safiullina, Yulia F. Osmolovskaya, Igor V. Zhirov, Olga V. Stukalova, Victor N. Shitov, Sergey N. Tereshchenko
Terapevticheskii arkhiv.2025; 97(8): 719. CrossRef
Long-Term Consequences of Cushing Syndrome: A Systematic Literature Review
Soraya Puglisi, Anna Maria Elena Perini, Cristina Botto, Francesco Oliva, Massimo Terzolo
The Journal of Clinical Endocrinology & Metabolism.2024; 109(3): e901. CrossRef
Perioperative Management of an Unusual Case of Dual Etiology Myopathy Undergoing Surgery for an Adrenal Tumor
Himanshu Sekhar Satapathy, Sakshi Gera, Lalit Sehgal
Journal of Indian College of Anaesthesiologists.2024; 3(2): 86. CrossRef
The Link between Mitochondrial Dysfunction and Sarcopenia: An Update Focusing on the Role of Pyruvate Dehydrogenase Kinase 4
Min-Ji Kim, Ibotombi Singh Sinam, Zerwa Siddique, Jae-Han Jeon, In-Kyu Lee
Diabetes & Metabolism Journal.2023; 47(2): 153. CrossRef
Intelligent Systems for Muscle Tracking: A Review on Sensor‐Algorithm Synergy
Arjun Putcha, Tien Nguyen, Regina Smith, Rachel Choffin, Wubin Bai
Advanced Intelligent Systems.2023;[Epub] CrossRef
Sarcopenia in youth
Han Na Jung, Chang Hee Jung, You-Cheol Hwang
Metabolism.2023; 144: 155557. CrossRef
Cushing Syndrome
Martin Reincke, Maria Fleseriu
JAMA.2023; 330(2): 170. CrossRef
Musculoskeletal complications of Cushing syndrome
Dorota Leszczyńska, Alicja Szatko, Lucyna Papierska, Wojciech Zgliczyński, Piotr Glinicki
Rheumatology.2023; 61(4): 271. CrossRef
Circulating myomiRNAs as biomarkers in patients with Cushing’s syndrome
C. Pivonello, R. Patalano, C. Simeoli, T. Montò, M. Negri, F. Amatrudo, N. Di Paola, A. Larocca, E. M. Crescenzo, R. Pirchio, D. Solari, C. de Angelis, R. S. Auriemma, L. M. Cavallo, A. Colao, R. Pivonello
Journal of Endocrinological Investigation.2023; 47(3): 655. CrossRef
Low-grade inflammation during the glucocorticoid withdrawal phase in patients with Cushing's syndrome
Frederick Vogel, Leah Braun, Stephanie Zopp, Elisabeth Nowak, Jochen Schreiner, Irina Benz, German Rubinstein, Heike Künzel, Katrin Ritzel, Matthias Kroiss, Jürgen Honegger, Felix Beuschlein, Katharina Schilbach, Daniel Teupser, Martin Bidlingmaier, Marti
European Journal of Endocrinology.2023; 188(4): 375. CrossRef
An odd case of immune-mediated necrotizing myopathy, complicated with sagittal, transverse and sigmoid sinus thrombosis
Andreea Trandafir, Violeta Claudia Bonjincă, Delia Tulba, Gelu Onose
Balneo and PRM Research Journal.2023; 14(Vol.14, no): 630. CrossRef
Morbidität und Mortalität beim Cushing-Syndrom
Frederick Vogel, Leah Braun, Martin Reincke
Der Internist.2022; 63(1): 34. CrossRef
Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside
Vittoria Favero, Arianna Cremaschi, Chiara Parazzoli, Alberto Falchetti, Agostino Gaudio, Luigi Gennari, Alfredo Scillitani, Fabio Vescini, Valentina Morelli, Carmen Aresta, Iacopo Chiodini
International Journal of Molecular Sciences.2022; 23(2): 673. CrossRef
Long‐term morbidity and mortality in patients with Cushing's syndrome
Leah T. Braun, Frederick Vogel, Martin Reincke
Journal of Neuroendocrinology.2022;[Epub] CrossRef
Clinical presentation and etiology of Cushing's syndrome: Data from ERCUSYN
Elena Valassi
Journal of Neuroendocrinology.2022;[Epub] CrossRef
Pyruvate dehydrogenase kinase 4 promotes ubiquitin–proteasome system‐dependent muscle atrophy
Ibotombi Singh Sinam, Dipanjan Chanda, Themis Thoudam, Min‐Ji Kim, Byung‐Gyu Kim, Hyeon‐Ji Kang, Jung Yi Lee, Seung‐Hoon Baek, Shin‐Yoon Kim, Bum Jin Shim, Dongryeol Ryu, Jae‐Han Jeon, In‐Kyu Lee
Journal of Cachexia, Sarcopenia and Muscle.2022; 13(6): 3122. CrossRef
Consensus on diagnosis and management of Cushing's disease: a guideline update
Maria Fleseriu, Richard Auchus, Irina Bancos, Anat Ben-Shlomo, Jerome Bertherat, Nienke R Biermasz, Cesar L Boguszewski, Marcello D Bronstein, Michael Buchfelder, John D Carmichael, Felipe F Casanueva, Frederic Castinetti, Philippe Chanson, James Findling
The Lancet Diabetes & Endocrinology.2021; 9(12): 847. CrossRef

Mineral, Bone & Muscle
Update on Glucocorticoid Induced Osteoporosis: Soo-Kyung Cho, Yoon-Kyoung Sung; Endocrinol Metab. 2021;36(3):536-543. Published online June 1, 2021; DOI: https://doi.org/10.3803/EnM.2021.1021

12,290 View
444 Download
24 Web of Science
28 Crossref

Abstract PDF PubReader ePub

Glucocorticoids are used to treat many autoimmune and inflammatory diseases. However, an adverse systemic effect is a deleterious effect on bone, which may lead to glucocorticoid-induced osteoporosis, characterized by a rapid and transient increase in bone resorption and fracture risk, which may increase rapidly within 3 months of commencing oral glucocorticoids. Therefore, early risk assessment and intervention are crucial for preventing fractures in patients receiving glucocorticoids. Recent practice guidelines recommend an assessment for fracture risk in patients beginning or receiving glucocorticoids for more than 3 months, and they have suggested fracture risk assessment tool values for identifying patients who need preventive treatment. Bisphosphonates are currently the recommended first-line therapy for the prevention and treatment of glucocorticoid-induced osteoporosis. These have been shown to increase the bone mineral density in the spine and hip and to decrease the incidence of vertebral fractures. Recently, a more potent antiresorptive agent, denosumab, has been shown to increase the bone density in patients receiving glucocorticoids. Teriparatide has been shown to have a preventive effect on vertebral fractures, but not on nonvertebral fractures. In this article we aimed to provide an update on glucocorticoid-induced osteoporosis by focusing on the assessment of its risk and treatment options.

Citations

Citations to this article as recorded by

A novel cohort to assess longitudinal glucocorticoid toxicity in individuals with rheumatic diseases: objectives, design, and initial baseline characteristics of the LONG-TOX cohort
Naomi J. Patel, Jiaqi Wang, Bohang Jiang, Isha Jha, Grace A. McMahon, Aubree E. McMahon, Tania Chiha, Hyon K. Choi, John H. Stone
Seminars in Arthritis and Rheumatism.2026; 76: 152897. CrossRef
Investigating the preventive effects of pulsed electromagnetic fields on glucocorticoid-induced osteoporosis in rats
Shuai Ding, Guangquan Zhang, Yanzheng Gao, Zhiqiang Hou, Fuqiang Shao
Scientific Reports.2025;[Epub] CrossRef
Dual-target nanotherapy for vascular endothelium and bone mesenchymal stem cells halt steroid-induced osteonecrosis of the femoral head progression
Wenbo Yang, Qing Pan, Yizhong Peng, Yuxiang Hu, Yongzhi Cui, Zengwu Shao, Chunqing Meng, Hong Wang, Wei Huang
Journal of Controlled Release.2025; 380: 219. CrossRef
Denosumab in the Management of Glucocorticoid-Induced Osteoporosis: Long-Term Efficacy and Secondary Fracture Outcomes
Sian-Siang Liao, Ya-Lian Deng, Chiann-Yi Hsu, Hsu-Tung Lee, Chi-Ruei Li, Chih-Chan Yang
Journal of Clinical Medicine.2025; 14(5): 1633. CrossRef
In vitro and in vivo anti-osteoporotic effects of different fractions from Xanthoceras sorbifolium wood
Dandan Wu, Xinyue Yang, Qianqian Xu, Zhiwei Yao, Chengbin Shan, Haiyan Xu, Chaomei Ma
Natural Product Research.2025; : 1. CrossRef
Understanding Glucocorticoid-induced Osteoporosis: Causes, Effects and Management
Mozhdeh Ghamari, Farnoosh Ebrahimzadeh, Kamila Hashemzadeh
Indian Journal of Rheumatology.2025;[Epub] CrossRef
Structural characterization of Morinda officinalis How polysaccharide and its anti-osteoporotic effects via oxidative stress modulation
Huifang Lai, Yijie Liang, Lishan He, Lijun Guo, Chenlu Deng, Xiaoping Wang
International Journal of Biological Macromolecules.2025; 319: 145616. CrossRef
Managing Adverse Effects Associated with Long-Term Glucocorticoid Use
Mi Kyung Kim
The Korean Journal of Medicine.2025; 100(4): 158. CrossRef
Columbianadin Ameliorate Osteoporosis Against Glucocorticoid Induced Osteoporosis in Rats via Alteration of RANK/RANKL/OPG Signaling Pathway
Songbo Mao, Chuntao Xu, Lin Zou
Journal of Biochemical and Molecular Toxicology.2025;[Epub] CrossRef
Effect of pigment epithelium-derived factor on prostaglandin E2 receptors (EP2/EP4) in glucocorticoid-induced osteoporosis in rats
Zerrin Kutlu, Zekai Halici, Fatih Alper, Erdem Toktay, Adem Maman, Hamza Halici, Zafer Bayraktutan, Ahmet Yalcin
Journal of Pharmacy and Pharmacology.2025;[Epub] CrossRef
Glucocorticoid-induced osteoporosis: clinical and pathogenetic aspects and correction possibilities
T. Potupchik, E. Kapustina, V. Zhidkov, L. Boeva, E. Klyuchnikova
Vrach.2025; : 11. CrossRef
Nuclear receptors as therapeutic targets in metabolic and cardiovascular disorders
Feifei Li, Qiujing Chen, Yang Dai, Lin Lu
iScience.2025; 28(12): 114042. CrossRef
Vitamin K2 Protects Against Glucocorticoid-Induced Osteoporosis by Activating the NRF2/FSP1 Pathway to Inhibit Osteoblast Ferroptosis
Zhichao Zhang, Xing Rong, Qinghua Ren, Yuying Kou, Jie Guo, Minqi Li
Drug Design, Development and Therapy.2025; Volume 19: 11525. CrossRef
Osteoporosis in autoimmune diseases
Snežana Tomašević-Todorović, Nataša Ilić, Damjan Savić, Sandra Jelčić
Srpski medicinski casopis Lekarske komore.2025; 6(4): 373. CrossRef
Guía de práctica clínica para la prevención, el diagnóstico y el tratamiento de la osteoporosis inducida por glucocorticoides. Asociación Colombiana de Reumatología, 2023
Monique Chalem, Noemi Casas, Aura María Domínguez, Daniel Gerardo Fernández, Andrés González, Edwin Jáuregui, José Fernando Molina, Diana Nathalie Rincón, Carlos Enrique Toro-Gutiérrez, Francisco Juan Vargas Grajales, Susan Martínez, Linda Ibatá
Revista Colombiana de Reumatología.2024; 31(3): 365. CrossRef
Clinical practice guideline for the prevention, diagnosis, and treatment of glucocorticoid-induced osteoporosis. Colombian Association of Rheumatology, 2023
Monique Chalem, Noemi Casas, Aura María Domínguez, Daniel Gerardo Fernández, Andrés González, Edwin Jáuregui, José Fernando Molina, Diana Nathalie Rincón, Carlos Enrique Toro-Gutiérrez, Francisco Juan Vargas Grajales, Susan Martínez, Linda Ibatá
Revista Colombiana de Reumatología (English Edition).2024; 31(3): 365. CrossRef
Exploring the Role of Hormones and Cytokines in Osteoporosis Development
Egemen Umur, Safiye Betül Bulut, Pelin Yiğit, Emirhan Bayrak, Yaren Arkan, Fahriye Arslan, Engin Baysoy, Gizem Kaleli-Can, Bugra Ayan
Biomedicines.2024; 12(8): 1830. CrossRef
Comparative performance analysis of large language models: ChatGPT-3.5, ChatGPT-4 and Google Gemini in glucocorticoid-induced osteoporosis
Linjian Tong, Chaoyang Zhang, Rui Liu, Jia Yang, Zhiming Sun
Journal of Orthopaedic Surgery and Research.2024;[Epub] CrossRef
Antiosteoporosis and bone protective effect of alpinumisoflavone in steroid-induced osteoporosis rats via alteration of apoptosis, inflammatory and RANK/RANKL/OPG signaling pathway
Jie Lian, Jun-Long Qu, Guo-Wei Zhao, Xu-Biao Ji
Asian Pacific Journal of Tropical Biomedicine.2024; 14(10): 436. CrossRef
Mechanism of MiR-145a-3p/Runx2 pathway in dexamethasone impairment of MC3T3-E1 osteogenic capacity in mice
Hang Wu, Xinghua Liao, Tingrui Wu, Bin Xie, Sicheng Ding, Yiren Chen, Lijun Song, Bo Wei, Gary S. Stein
PLOS ONE.2024; 19(11): e0309951. CrossRef
Protective role of 3-oxypyridine derivatives in rats’ steroid-induced osteoporosis associated with reduced oxidative stress and recovery of nitric oxide formation
A. P. Danilenko, K. S. Trunov, M. V. Pokrovsky, L. M. Danilenko, M. V. Korokin, O. S. Gudyrev, A. A. Khentov, N. P. Masalytina, I. A. Tatarenkova, A. V. Cherednichenko, E. V. Boeva, I. S. Koklin, E. I. Taran
Pharmacy & Pharmacology.2023; 11(1): 48. CrossRef
Influence of Piper sarmentosum Aqueous Extract on the Expression of Osteocalcin in Glucocorticoid-induced Osteoporotic Rats
Elvy Suhana Mohd Ramli, Ima Nirwana Soelaiman, Suryati Mohd Thani, Nurul Huda Mohd Nor, Nurul Hayati Mohamad Zainal, Siti Saleha Masrudin, Siti Fadziyah Mohamad Asri
Malaysian Journal of Medicine and Health Sciences.2023; 19(s12): 115. CrossRef
Vitamin D Supplementation in Patients with Juvenile Idiopathic Arthritis
Chao-Yi Wu, Huang-Yu Yang, Shue-Fen Luo, Jing-Long Huang, Jenn-Haung Lai
Nutrients.2022; 14(8): 1538. CrossRef
A Review on the Molecular Mechanisms of Action of Natural Products in Preventing Bone Diseases
Innocent U. Okagu, Timothy P. C. Ezeorba, Rita N. Aguchem, Ikenna C. Ohanenye, Emmanuel C. Aham, Sunday N. Okafor, Carlotta Bollati, Carmen Lammi
International Journal of Molecular Sciences.2022; 23(15): 8468. CrossRef
Antiosteoporosis and bone protective effect of nimbolide in steroid‐induced osteoporosis rats
Jiang Huo, Yu Ding, Xinyuan Wei, Qi Chen, Bin Zhao
Journal of Biochemical and Molecular Toxicology.2022;[Epub] CrossRef
Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Lianghai Jiang, Jian Dong, Jianwei Wei, Lantao Liu
BMC Musculoskeletal Disorders.2022;[Epub] CrossRef
Improvement in Glucocorticoid-Induced Osteoporosis on Switching from Bisphosphonates to Once-Weekly Teriparatide: A Randomized Open-Label Trial
Toshihiro Nanki, Mai Kawazoe, Kiyoko Uno, Wataru Hirose, Hiroaki Dobashi, Hiroshi Kataoka, Toshihide Mimura, Hiroshi Hagino, Hajime Kono
Journal of Clinical Medicine.2022; 12(1): 292. CrossRef
Understanding of Glucocorticoid Induced Osteoporosis
Chang-Nam Son
Keimyung Medical Journal.2021; 40(2): 69. CrossRef

Original Articles

Clinical Study
Effects of Systemic Glucocorticoid Use on Fracture Risk: A Population-Based Study: Ji Weon Koh, Junkang Kim, Hyemin Cho, Yong-Chan Ha, Tae-Young Kim, Young-Kyun Lee, Ha Young Kim, Sunmee Jang; Endocrinol Metab. 2020;35(3):562-570. Published online September 22, 2020; DOI: https://doi.org/10.3803/EnM.2020.659

9,859 View
231 Download
13 Web of Science
15 Crossref

Abstract PDF PubReader ePub

Background
Long-term glucocorticoid use increases fracture risk by reducing bone mass. This study evaluated the relationship between hip and vertebral fractures and the total amount of systematic glucocorticoid use.
Methods
We randomly selected 1,896,159 people aged 20 to 100 years who participated in the National Health Checkup program in 2006. The amount of glucocorticoids prescribed was calculated based on the defined daily dose (DDD). The total DDD was obtained by adding oral and parenteral glucocorticoids for 6 months from the index date. Subjects were categorized into four groups according to total glucocorticoid DDDs: non-users (DDDs=0), low users (0< DDDs ≤45), intermediate users (45< DDDs ≤90), and high users (90< DDDs). We followed them for 2 years. A multivariate Cox proportional hazard model was used to evaluate the effects of the total amount of glucocorticoid use on hip and vertebral fractures.
Results
Higher glucocorticoid use was associated with a higher risk of vertebral fracture. Relative to non-users, the vertebral fracture risk was 1.39 times higher in the low-user group, 1.94 times higher in the intermediate-user group, and 2.43 times higher in the highuser group. The risk of hip fracture was 1.72 times higher in intermediate users and 3.28 times higher in high users than in non-users.
Conclusion
As the amount of glucocorticoid use for 6 months increased, the risk of hip and vertebral fractures became higher. In order to prevent fractures, it is necessary for doctors to evaluate the total amount of glucocorticoid prescribed to the patient and to provide appropriate treatment.

Citations

Citations to this article as recorded by

Association between femoral localized cortical thickening (“beaking” or “flaring”) and bisphosphonate duration in glucocorticoid-induced osteoporosis
Yudai Yano, Sachiko Kawasaki, Takaaki Kosugi, Takahiro Mui, Hiroyuki Tamaki, Hikari Tasaki, Masatoshi Nishimoto, Kaori Tanabe, Masahiro Eriguchi, Ken-ichi Samejima, Yoshinobu Uchihara, Masakazu Okamoto, Yasuhiro Akai, Kazuhiko Tsuruya, Kenji Kawamura
Journal of Bone and Mineral Metabolism.2026;[Epub] CrossRef
Incidence, prevalence, and predictors of osteoporotic fracture in adult lung transplant recipients
Elisabeth Ng, Shanal Kumar, Eldho Paul, Daniel Bennett, Luisa Rosi, Louise Fuller, Lauren Chiu, Shoshana Sztal-Mazer, Steven Ivulich, Greg Snell, Leon A. Bach, Kathryn L. Hackman
JHLT Open.2025; 7: 100182. CrossRef
Progressive resisted exercise program combined with aerobic exercise on osteoporotic systemic lupus erythematous patients: a prospective randomized controlled trial
Hadaya Mosaad Eladl, Nabil Mahmoud Abdel-Aal, Khadra Mohamed Ali, Doaa Ayoub Elimy, Nesma M. Allam
Disability and Rehabilitation.2025; 47(15): 3887. CrossRef
Risk factors of osteoporotic vertebral fracture cascade and the relationship between blood glucose control and fracture occurrence
Yuyu Fan, Junjie Qiao, Lixiang Ding, Hongxing Song, Yu Hou, Meng Yi, Xiutong Fang
Journal of Back and Musculoskeletal Rehabilitation.2025; 38(2): 334. CrossRef
Evaluating the relationship between bone density, osteoporosis, and some risk factors
Tran Thua Nguyen, Le Thi Ngoc Uyen, Phan Thị Minh Phương, Trần Thị Cẩm Tú, Nguyễn Thị Huệ
Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế.2025; 17(2): 78. CrossRef
The link between osteoporosis and cardiovascular diseases: a review of shared mechanisms, risk factors, and therapeutic approaches
Mohammad Hasan Sharafi, Afshin Nazari, Mostafa Cheraghi, Faraz Souri, Morteza Bakhshesh
Osteoporosis International.2025; 36(7): 1129. CrossRef
Nuclear receptors as therapeutic targets in metabolic and cardiovascular disorders
Feifei Li, Qiujing Chen, Yang Dai, Lin Lu
iScience.2025; 28(12): 114042. CrossRef
Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide h
Masayuki Iki, Kenji Fujimori, Shinichi Nakatoh, Junko Tamaki, Shigeyuki Ishii, Nobukazu Okimoto, Hironori Imano, Sumito Ogawa
Osteoporosis International.2024; 35(5): 805. CrossRef
Low-dose glucocorticoid increase the risk of fracture in postmenopausal women with low bone mass: a retrospective cohort study
So Young Park, Seong Hee Ahn, Gi Hwan Bae, Sunmee Jang, Mi Kyung Kwak, Ha Young Kim, Se Hwa Kim
Osteoporosis International.2024; 35(10): 1779. CrossRef
Chronic airway disease as a major risk factor for fractures in osteopenic women: Nationwide cohort study
Sung Hye Kong, Ae Jeong Jo, Chan Mi Park, Kyun Ik Park, Ji Eun Yun, Jung Hee Kim
Frontiers in Endocrinology.2023;[Epub] CrossRef
Bad to the bones: prescribing of drugs for the prevention and treatment of osteoporosis in patients on chronic glucocorticoids
Sarah J. Billups, Vinh K Thai, Jacob Denkins, Ian C. Dettman, Micol S. Rothman
Archives of Osteoporosis.2023;[Epub] CrossRef
High Risk of Fractures Within 7 Years of Diagnosis in Asian Patients With Inflammatory Bowel Diseases
Hyung Jin Ahn, Ye-Jee Kim, Ho-Su Lee, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Beom-Jun Kim, Sang Hyoung Park
Clinical Gastroenterology and Hepatology.2022; 20(5): e1022. CrossRef
Challenges in the diagnosis and management of glucocorticoid‐induced osteoporosis in younger and older adults
Madhuni Herath, Bente Langdahl, Peter R. Ebeling, Frances Milat
Clinical Endocrinology.2022; 96(4): 460. CrossRef
Comparative effectiveness of bisphosphonate treatments for the prevention of re-fracture in glucocorticoid-induced osteoporosis: protocol for a systematic review and meta-analysis
Hongmin Chu, Bo-Hyoung Jang, GaYoon Kim, Seowoo Bae, Hyeju Lee, Seonghee Nam, Jeonghoon Ahn
BMJ Open.2022; 12(9): e062537. CrossRef
Why Do We Need Proactive Management for Fracture Prevention in Long-Term Glucocorticoid Users?
Han Seok Choi
Endocrinology and Metabolism.2020; 35(3): 549. CrossRef

Clinical Study
Characteristics of Korean Patients with Primary Adrenal Insufficiency: A Registry-Based Nationwide Survey in Korea: A Ram Hong, Ohk-Hyun Ryu, Seong Yeon Kim, Sang Wan Kim; Endocrinol Metab. 2017;32(4):466-474. Published online December 14, 2017; DOI: https://doi.org/10.3803/EnM.2017.32.4.466

9,600 View
79 Download
16 Web of Science
14 Crossref

Abstract PDF Supplementary Material PubReader

Background

Primary adrenal insufficiency (PAI) is a rare, potentially life-threatening condition. There are few Korean studies on PAI, and most have had small sample sizes. We aimed to examine the etiology, clinical characteristics, treatment, and mortality of PAI in Korean patients.

Methods

A nationwide, multicenter, registry-based survey was conducted to identify adults diagnosed with or treated for PAI at 30 secondary or tertiary care institutions in Korea between 2000 and 2014.

Results

A total of 269 patients with PAI were identified. The prevalence of PAI was 4.17 per million. The estimated incidence was 0.45 per million per year. The mean age at diagnosis was 49.0 years, and PAI was more prevalent in men. Adrenal tuberculosis was the most common cause of PAI in patients diagnosed before 2000; for those diagnosed thereafter, adrenal metastasis and tuberculosis were comparable leading causes. The etiology of PAI was not identified in 34.9% of cases. Of the patients receiving glucocorticoid replacement therapy, prednisolone was more frequently administered than hydrocortisone (69.4% vs. 26.5%, respectively), and only 27.1% of all patients received fludrocortisone. We observed an increased prevalence of metabolic disease and osteoporosis during the follow-up period (median, 60.2 months). The observed overall mortality and disease-specific mortality rates were 11.9% and 3.1%, respectively.

Conclusion

The prevalence of PAI is significantly lower in Koreans than in reports from Western countries. The high frequency undetermined etiology in patients with PAI suggests the need to reveal accurate etiology of PAI in Korea.

Citations

Citations to this article as recorded by

Premature ovarian insufficiency: When ovaries retire early
Stella Rizalina Sasha Sugianto, Lisa Webber, Farah Husain Safdar, Veronique Viardot-Foucault, Sadhana Nadarajah, Jiin Ying Lim, Ee Shien Tan, Tze Tein Yong, Rukshini Puvanendran
Annals of the Academy of Medicine, Singapore.2025; 54(3): 178. CrossRef
Adrenal Insufficiency in Adults
Anand Vaidya, James Findling, Irina Bancos
JAMA.2025; 334(8): 714. CrossRef
Genetic and phenotypic spectrum of non-21-hydroxylase-deficiency primary adrenal insufficiency in childhood: data from 111 Chinese patients
Ying Duan, Wanqi Zheng, Yu Xia, Huiwen Zhang, Lili Liang, Ruifang Wang, Yi Yang, Kaichuang Zhang, Deyun Lu, Yuning Sun, Lianshu Han, Yongguo Yu, Xuefan Gu, Yu Sun, Bing Xiao, Wenjuan Qiu
Journal of Medical Genetics.2024; 61(1): 27. CrossRef
Approach to the Patient: Diagnosis of Primary Adrenal Insufficiency in Adults
Marianne Øksnes, Eystein S Husebye
The Journal of Clinical Endocrinology & Metabolism.2023; 109(1): 269. CrossRef
Epidemiology and Causes of Primary Adrenal Insufficiency in Children: A Population-Based Study
Joonatan Borchers, Eero Pukkala, Outi Mäkitie, Saila Laakso
The Journal of Clinical Endocrinology & Metabolism.2023; 108(11): 2879. CrossRef
Primary Adrenal Insufficiency in Acute Progressive Systemic Inflammation Accompanied by Latent Tuberculosis: A Case Report
Kasumi Nishikawa, Mizuki Nitta, Shoma Tanaka, Chiaki Sano, Ryuichi Ohta
Cureus.2023;[Epub] CrossRef
What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study
S. Puglisi, A. Rossini, I. Tabaro, S. Cannavò, F. Ferrau’, M. Ragonese, G. Borretta, M. Pellegrino, F. Dughera, A. Parisi, A. Latina, A. Pia, M. Terzolo, G. Reimondo
Journal of Endocrinological Investigation.2021; 44(4): 865. CrossRef
Adrenal insufficiency
Eystein S Husebye, Simon H Pearce, Nils P Krone, Olle Kämpe
The Lancet.2021; 397(10274): 613. CrossRef
Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion
A. M. Isidori, G. Arnaldi, M. Boscaro, A. Falorni, C. Giordano, R. Giordano, R. Pivonello, C. Pozza, E. Sbardella, C. Simeoli, C. Scaroni, A. Lenzi
Journal of Endocrinological Investigation.2020; 43(5): 683. CrossRef
Novel ABCD1 Gene Mutation in a Korean Patient with X-Linked Adrenoleukodystrophy Presenting with Addison's Disease
Yun Kyung Cho, Seo-Young Lee, Sang-Wook Kim
Endocrinology and Metabolism.2020; 35(1): 188. CrossRef
Encountering COVID-19 as Endocrinologists
Eun-Jung Rhee, Jung Hee Kim, Sun Joon Moon, Won-Young Lee
Endocrinology and Metabolism.2020; 35(2): 197. CrossRef
Prednisolone is associated with a worse bone mineral density in primary adrenal insufficiency
Kathrin R Frey, Tina Kienitz, Julia Schulz, Manfred Ventz, Kathrin Zopf, Marcus Quinkler
Endocrine Connections.2018; 7(6): 811. CrossRef
The potential role for infections in the pathogenesis of autoimmune Addison’s disease
A Hellesen, E Bratland
Clinical and Experimental Immunology.2018; 195(1): 52. CrossRef
Evaluation and Treatment of Adrenal Dysfunction in the Primary Care Environment
Shannon Cole
Nursing Clinics of North America.2018; 53(3): 385. CrossRef

Review Article

Glucocorticoid-Induced Diabetes Mellitus: An Important but Overlooked Problem: Sunghwan Suh, Mi Kyoung Park; Endocrinol Metab. 2017;32(2):180-189. Published online May 29, 2017; DOI: https://doi.org/10.3803/EnM.2017.32.2.180

35,594 View
922 Download
142 Web of Science
158 Crossref

Abstract PDF PubReader ePub

Glucocorticoids are widely used as potent anti-inflammatory and immunosuppressive drugs to treat a wide range of diseases. However, they are also associated with a number of side effects, including new-onset hyperglycemia in patients without a history of diabetes mellitus (DM) or severely uncontrolled hyperglycemia in patients with known DM. Glucocorticoid-induced diabetes mellitus (GIDM) is a common and potentially harmful problem in clinical practice, affecting almost all medical specialties, but is often difficult to detect in clinical settings. However, scientific evidence is lacking regarding the effects of GIDM, as well as strategies for prevention and treatment. Similarly to nonsteroid-related DM, the principles of early detection and risk factor modification apply. Screening for GIDM should be considered in all patients treated with medium to high doses of glucocorticoids. Challenges in the management of GIDM stem from wide fluctuations in postprandial hyperglycemia and the lack of clearly defined treatment protocols. Together with lifestyle measures, hypoglycemic drugs with insulin-sensitizing effects are indicated. However, insulin therapy is often unavoidable, to the point that insulin can be considered the drug of choice. The treatment of GIDM should take into account the degree and pattern of hyperglycemia, as well as the type, dose, and schedule of glucocorticoid used. Moreover, it is essential to instruct the patient and/or the patient's family about how to perform the necessary adjustments. Prospective studies are needed to answer the remaining questions regarding GIDM.

Citations

Citations to this article as recorded by

A systematic review of glucocorticoid use in type 1 diabetes: Glycaemic effects and clinical management strategies
Alexandra Katz, Aidan Shulkin, Asmaa Housni, Amélie Roy‐Fleming, Rémi Rabasa‐Lhoret, Jean‐Francois Yale, Michael A. Tsoukas, Tricia M. Peters, Anne‐Sophie Brazeau
Diabetes, Obesity and Metabolism.2026;[Epub] CrossRef
Corticosteroid Use and Atrial Fibrillation: Exploring Underlying Mechanisms, FAERS Disproportionality Analysis, and a Meta-Analysis of Clinical Studies
Harri Hardi, Agian Jeffilano Barinda, Ananda Pipphali Vidya, Karen Elliora Utama, Liganda Endo Mahata
Cardiovascular Toxicology.2026;[Epub] CrossRef
Disease-specific clustering is seen among first-degree relatives in autoimmune rheumatic diseases: A cross-sectional, multi-centre study
S Chandrashekara, Padmanabha Shenoy, Uma Kumar, Sapan Pandya, Alakendu Ghosh, Rajkiran Dudam, Arghya Chattopadhyay, Apurva Khare, Rudra Prosad Goswami, Banwari Sharma
Clinical Immunology Communications.2026; 9: 23. CrossRef
Glucocorticoid-Induced Hyperglycemia in Patients with Cancer: Mechanisms, Clinical Implications, and Management Strategies
Luana Lury Morikawa, Marcia Nery, Marcos Tadashi Kakitani Toyoshima
Endocrine Practice.2026;[Epub] CrossRef
Modeling the spectrum of type 2 diabetes in mice
Lili Grieco-St-Pierre, Myriam P Hoyeck, Jennifer L Estall, Jennifer E Bruin
Endocrinology.2026;[Epub] CrossRef
Usefulness of Indian Diabetes Risk Score in Predicting Treatment-Induced Hyperglycemia in Women Undergoing Adjuvant Chemotherapy for Breast Cancer
Krishna Prasad, Sanath Hegde, Suresh Rao, Rhea Katherine D'souza, Thomas George, Sucharitha Suresh, Manjeshwar Shrinath Baliga
South Asian Journal of Cancer.2025; 14(01): 004. CrossRef
Letter to the Editor From Hao and Xue: “Checkpoint Inhibitor-Associated Autoimmune Diabetes Mellitus Is Characterized by C-Peptide Loss and Pancreatic Atrophy”
Lu Hao, Jisu Xue
The Journal of Clinical Endocrinology & Metabolism.2025; 110(2): e550. CrossRef
Management of Glucocorticoid-Induced Hyperglycemia in Cancer Patients: A Feasibility Study
Jenny Wright, Theresa Nielsen, Samantha Burns, Nicole Weekes, Anisha Pradhan, Judeil Krlan Teus, Gemma McErlean
Clinical Nursing Research.2025; 34(1): 3. CrossRef
Glycated haemoglobin and serum fructosamine concentrations in sick, non‐diabetic dogs receiving oral prednisolone
Ioannis L. Oikonomidis, Alexandra Daravigka, Jose J. Ceron, Asta Tvarijonaviciute, Froso Lambrou, Zoi Tzenetidou, Alexandros O. Konstantinidis, Nectarios Soubasis
Veterinary Record.2025;[Epub] CrossRef
Steroid-induced diabetes in lupus nephritis patients: Classic risk factors or a different type of diabetes?
Cristian Alejandro Dimas-Ramírez, Luis André Fortanell-Meza, Diego San Agustín-Morales, Eduardo Brenner-Muslera, Juan Manuel Mejía-Vilet, Paloma Almeda-Valdes, Paola Vázquez-Cárdenas, Javier Merayo-Chalico, Ana Barrera-Vargas
Lupus.2025; 34(3): 234. CrossRef
Saudi National Clinical Practice Guidelines for Management of Adult Systemic Lupus Erythematosus
Ahmed H. Al-Jedai, Hajer Y. Almudaiheem, Ibrahim A. Al-Homood, Ibrahim Almaghlouth, Sami M. Bahlas, Abdulaziz Mohammed Alolaiwi, Mohammad Fatani, Maysa Tariq Eshmawi, Bedor A. AlOmari, Khalidah Ahmed Alenzi, Rayan G. Albarakati, Nayef Al Ghanim
Current Rheumatology Reviews.2025; 21(1): 70. CrossRef
Quercetin inhibits steroid-induced hypergluconeogenesis in Saccharomyces cerevisiae
Victor Arokia Doss, Gowtham Subramaniam, Keerthana Manoharan
Future Journal of Pharmaceutical Sciences.2025;[Epub] CrossRef
Rethinking corticosteroids use in oncology
Pierrick Martinez, Jean-Marc Sabatier
Frontiers in Pharmacology.2025;[Epub] CrossRef
Molecular interactions of glucocorticoid and mineralocorticoid receptors define novel transcription and biological functions
Tatsuya Sueyoshi, Maria G. Petrillo, Christine M. Jewell, Carl D. Bortner, Lalith Perera, Xiaojiang Xu, Felipe I. Aguayo, David Diaz-Jimenez, Anastasia G. Robinson, Molly E. Cook, Robert H. Oakley, John A. Cidlowski
Journal of Biological Chemistry.2025; 301(5): 108488. CrossRef
Nutritional status in patients with COPD and its impact on biochemical status: A narrative review
Azhimamatova Rakhima, Abdurashitova Diloramkhan, Tazhibaeva Feruza, Tursunkulova Chynara, Kebekova Aizat, Sabirakhan Mamatova, Roman Kalmatov, Salieva Rana
Journal of Advanced Pharmacy Education and Research.2025; 15(2): 31. CrossRef
Add-On Treatment with Gliclazide for Cancer Patients with Type 2 Diabetes Undergoing Cyclic Glucocorticoid-Containing Chemotherapy
Seung Eun Lee, Ju-Hyun Park, Dalyong Kim, Hyun-A Lee, Yun Seong Kang, Young Soon Yoon, Yun Jeong Jeong, Han Seok Choi, Kyoung-Ah Kim
Biomedicines.2025; 13(5): 1101. CrossRef
Intertwined pathways of SARS-CoV2 infection and its clinical repercussions on glucose homeostasis: Exploring the Rise of New-Onset Diabetes
Vertika Awasthi, Rupinder Kaur, Chirag Pasricha, Pratima Kumari, Suruchi Chaubey, Sarita Jangra, Sanjana Mehta, Ravinder Singh
Obesity Medicine.2025; : 100624. CrossRef
Lipid Hormones at the Intersection of Metabolic Imbalances and Endocrine Disorders
Maria-Zinaida Dobre, Bogdana Virgolici, Ruxandra Cioarcă-Nedelcu
Current Issues in Molecular Biology.2025; 47(7): 565. CrossRef
STUDI PENGGUNAAN GLUKOKORTIKOID PADA PASIEN PENYAKIT PARU OBSTRUKTIF KRONIK DI RSUD R.T. NOTOPURO SIDOARJO
Audin Nur Affifah Febriyanti, Ira Purbosari, Fajar Jamaluddin Sandhori
Jurnal Sains dan Kesehatan.2025; 6(2): 116. CrossRef
Glukokortikoidanwendung und Diabetes mellitus – Pathogenese, Diagnostik und Therapie
Lea Tschaidse, Matthias Auer, Nicole Reisch
Diabetologie und Stoffwechsel.2025; 20(04): 270. CrossRef
Hyperglycémies iatrogènes en dehors du virus de l’immunodéficience humaine
P. Treca, C. Amouyal
EMC - Endocrinologie - Nutrition.2025; 36(4): 1. CrossRef
A qualitative study to explore experiences and views of patients and their family members managing steroid‐induced hyperglycaemia (SIH) out of hospital
Nyangi Gityamwi, Suzanne van Even, Younes Ramazan Younes, Jo Armes, Benjamin C. T. Field
Diabetic Medicine.2025;[Epub] CrossRef
Protective Role of Gallic Acid Against Corticosterone-Induced Hepatic Toxicity: Modulation of Oxidative Stress and Inflammatory Pathways in Wistar Rats
Priyanka Tiwari, Prabhat Kumar, Saripella Srikrishna, Nikhat Jamal Siddiqi, Bechan Sharma
Toxics.2025; 13(10): 897. CrossRef
Stem cell transplant and graft versus host disease: designing and implementing a steroid-induced hyperglycemia tool kit
Linda Baer, Caitlin Omoregie, Frank Oley, Regina Carlisle, Christina Luszcak, Julia Blanchette, Claudia Lewis, Molly Gallogly, Susan Mazanec
Supportive Care in Cancer.2025;[Epub] CrossRef
Treating sarcoidosis: when less is more
Niamh Logan, Jessica Raja, Elisabetta A Renzoni
Current Opinion in Immunology.2025; 97: 102679. CrossRef
Transcranial Direct Current Stimulation (tDCS) in Diabetes: A Focused and Mechanistic Review of Symptom and Function Outcomes
James Chmiel, Donata Kurpas
Journal of Clinical Medicine.2025; 14(22): 7945. CrossRef
Current treatment for diabetes: a holistic approach
Niki G. Mourelatou, Dimitris Kounatidis, Natalia G. Vallianou, Giuseppe Daniele, Angela Dardano, Eleni Rebelos
Hormones.2025;[Epub] CrossRef
Drug-Induced Glucose Metabolism Disorders: Role of Aryl Hydrocarbon Receptor
Alevtina Y. Grishanova, Maria L. Perepechaeva
Journal of Xenobiotics.2025; 15(6): 206. CrossRef
Studi Penggunaan Glukokortikoid Pada Pasien Penyakit Paru Obstruktif Kronik Di RSUD R.T. Notopuro Sidoarjo
Audin Nur Affifah Febriyanti, Ira Purbosari, Fajar Jamaluddin Sandhori
Jurnal Sains dan Kesehatan.2025; : 116. CrossRef
Identification of MicroRNA Drug Targets for Alzheimer's and Diabetes Mellitus Using Network Medicine
Ricardo Castillo-Velazquez, Julio E. Castaneda-Delgado, Mariana H. Garcia-Hernandez, Bruno Rivas-Santiago, Sofia Ruiz-Hernandez, Eyra Liliana Ortiz-Perez, Juan C. Lopez-Alvarenga, Gildardo Rivera, Edgar E. Lara-Ramirez
Current Alzheimer Research.2025; 22(7): 522. CrossRef
Steroid-Induced Hyperglycaemia in a Patient With Possible Body Dissatisfaction: A Case Report
Chukwuebuka E Ohakpougwu, Wendy M Bebobru, Emmanuel Labram
Cureus.2025;[Epub] CrossRef
Continuous Glucose Monitoring of Steroid-Induced Hyperglycemia in Patients With Dermatologic Diseases
Monika Kleinhans, Lea Jessica Albrecht, Sven Benson, Dagmar Fuhrer, Joachim Dissemond, Susanne Tan
Journal of Diabetes Science and Technology.2024; 18(4): 904. CrossRef
COVID‐19 associated mucormycosis surge: A review on multi‐pathway mechanisms
Mohsen Pourazizi, Atousa Hakamifard, Alireza Peyman, Rasoul Mohammadi, Shakiba Dehghani, Najmeh Tavousi, Nastaran‐Sadat Hosseini, Hamed Azhdari Tehrani, Bahareh Abtahi‐Naeini
Parasite Immunology.2024;[Epub] CrossRef
Drug-induced hyperglycemia and diabetes
Marie-Anne Heurtebize, Jean-Luc Faillie
Therapies.2024; 79(2): 221. CrossRef
Immunosuppression in solid organ–transplant recipients and impact on nutrition support
Nicole K. Wilson, Ann D. Kataria
Nutrition in Clinical Practice.2024; 39(1): 109. CrossRef
The effect of different types of oral or intravenous corticosteroids on capillary blood glucose levels in hospitalized inpatients with and without diabetes
Vaishali Limbachia, Ian Nunney, Daniel J. Page, Hannah A. Barton, Leena K. Patel, Georgia N. Thomason, Stephan L. Green, Kieran F.J. Lewis, Ketan Dhatariya
Clinical Therapeutics.2024; 46(2): e59. CrossRef
Incidence and Characteristics of the Hyperosmolar Hyperglycemic State: A Danish Cohort Study
Emilie V. Rosager, Amalia Lærke K. Heltø, Cathrine U. Fox Maule, Lennart Friis-Hansen, Janne Petersen, Finn E. Nielsen, Steen B. Haugaard, Rasmus Gregersen
Diabetes Care.2024; 47(2): 272. CrossRef
Cortisol levels across the lifespan in common marmosets (Callithrix jacchus)
Matthew Lopez, Amaya Seidl, Kimberley A. Phillips
American Journal of Primatology.2024;[Epub] CrossRef
Belimumab in a Patient with Systemic Lupus Erythematosus with Juvenile Onset and Steroid-induced Diabetes: Clinical Case
Maria I. Kaleda, Irina P. Nikishina, Alesya V. Firsa
Current Pediatrics.2024; 22(6): 546. CrossRef
Optimal initial insulin dosage for managing steroid-induced hyperglycemia in hospitalized COVID-19 patients: A retrospective single-center study
Nuttavadee Ketaroonrut, Sasisopin Kiertiburanakul, Chutintorn Sriphrapradang
SAGE Open Medicine.2024;[Epub] CrossRef
Extended-Release Versus Immediate-Release Triamcinolone Acetonide in Patients Who Have Knee Osteoarthritis and Type 2 Diabetes Mellitus
Andrew I. Spitzer, Helena W. Rodbard, Sheikh Usman Iqbal, Masato Nakazawa, Mary DiGiorgi, Roy Winston
The Journal of Arthroplasty.2024; 39(9): S218. CrossRef
Important aspects of carbohydrate metabolism disorders development in hematology/oncology patients during therapy with glucocorticosteroids: a review of the literature
N. T. Vatutin, E. V. Sklyannaya, V. V. Gribov
Oncohematology.2024; 19(2): 118. CrossRef
The safety and use of perioperative dexamethasone in the perioperative management of primary sporadic supratentorial meningiomas
Felix Arlt, Alim Emre Basaran, Markus Vogel, Martin Vychopen, Clemens Seidel, Alonso Barrantes-Freer, Erdem Güresir, Johannes Wach
Frontiers in Oncology.2024;[Epub] CrossRef
The effect of AZD9567 vs. prednisolone on glycaemic control in patients with type 2 diabetes mellitus: Results from a phase 2a clinical trial
Philip Ambery, Grzegorz Zajac, Joachim Almquist, Susanne Prothon, Carol Astbury, Mary N. Brown, Szilard Nemes, Joselyne Nsabimana, Karl Edman, Lisa Öberg, Matti Lepistö, Goran Edenro, Inken Dillmann, Suman Mitra, Graham Belfield, Christina Keen, Tim Heise
British Journal of Clinical Pharmacology.2024; 90(8): 1921. CrossRef
Continuous glucose monitoring profile in COVID-19 patients with and without diabetes receiving methylprednisolone
Xingxing He, Guangchen Duan, Jingyi Lu, Yaxin Wang, Jinghao Cai, Yiqing Tong, Wei Wu, Xiaojing Ma, Qiming Feng, Jian Zhou
Endocrine.2024; 86(2): 556. CrossRef
DISFUNÇÕES RESPIRATÓRIAS FELINAS
Felipe Gaia de Sousa, Juliana Uchôa Ribeiro, Suzane Lilian Beier, Myrian Kátia Iser Teixeira
Veterinária e Zootecnia.2024; 31: 1. CrossRef
Review Artikel: Pengaruh Glukokortioid Terhadap Glukosa Darah Pasien Diabetes Melitus Tipe 2
Novia Ariani Dewi, Arina Titami
Jurnal Farmasi SYIFA.2024; 2(2): 68. CrossRef
Diabetic ketoacidosis in a patient with type 2 diabetes induced by multiple triggers: a case report and implications for clinical practice
Konstantinos Kitsios, Christina‐Maria Trakatelli
Practical Diabetes.2024; 41(3): 27. CrossRef
Endocrine Disorders and Peripheral Arterial Disease – A Series of Reviews Cushing Syndrome-Cortisol Excess
Poredoš P, Schernthaner GH, Blinc A, Mikhailidis DP, Jensterle M, Anagnostis P, Antignani PL, Bajuk Studen K, Šabović M, Ježovnik MK
Current Vascular Pharmacology.2024; 22(4): 236. CrossRef
Megestrol acetate as an overlooked cause of hyperglycemia in end-stage renal disease: A case of polypharmacy
John Aurora, Theresa Zheng, Julieta Rossi Fortunati, Feyza Erenler
Journal of the American Pharmacists Association.2024; 64(6): 102248. CrossRef
Corticothérapie : une nécessaire pluridisciplinarité au service du patient ?
Caroline Samhani, Sandra Tonnette
Soins.2024; 69(890): 52. CrossRef
The association of diabetes mellitus and routinely collected patient‐reported outcomes in patients with cancer. A real‐world cohort study
Dominik J. Ose, Emmanuel Adediran, Bayarmaa Mark, Krista Ocier, William A. Dunson JR, Cindy Turner, Belinda Taylor, Kim Svoboda, Andrew R. Post, Jennifer Leiser, Howard Colman, Cornelia M. Ulrich, Mia Hashibe
Cancer Medicine.2024;[Epub] CrossRef
Sars-Cov2 Induced Biochemical Mechanisms in Liver Damage and Intestinal Lesions
Liudmila V. Spirina, Vladimir N. Masunov, Denis A. Dyakov, Olga E. Akbasheva, Amina Y. Kebekbayeva, Igor Yu. Shuvalov, Nadezhda V. Masunova, Irina V. Kovaleva, Yumzhana Dagbaeva
Indian Journal of Clinical Biochemistry.2023; 38(4): 437. CrossRef
Mouse Pancreatic Peptide Hormones Probed at the Sub-Single-Islet Level: The Effects of Acute Corticosterone Treatment
Aleksandra Antevska, Connor C. Long, Samuel D. Dupuy, J. Jason Collier, Michael D. Karlstad, Thanh D. Do
Journal of Proteome Research.2023; 22(1): 235. CrossRef
Type 1 and other types of diabetes mellitus in the perioperative period. What the anaesthetist should know
Robert van Wilpe, Abraham H. Hulst, Sarah.E. Siegelaar, J. Hans DeVries, Benedikt Preckel, Jeroen Hermanides
Journal of Clinical Anesthesia.2023; 84: 111012. CrossRef
The Effects of Daily Prednisone and Tocilizumab on Hemoglobin A1c During the Treatment of Giant Cell Arteritis
Naomi J. Patel, Veronica Tozzo, John M. Higgins, John H. Stone
Arthritis & Rheumatology.2023; 75(4): 586. CrossRef
Characterization, evolution and risk factors of diabetes and prediabetes in a pediatric cohort of renal and liver transplant recipients
Sophie Welsch, Virginie Mailleux, Priscilla le Hardy de Beaulieu, Nadejda Ranguelov, Nathalie Godefroid, Annie Robert, Xavier Stephenne, Isabelle Scheers, Raymond Reding, Etienne M. Sokal, Philippe A. Lysy
Frontiers in Pediatrics.2023;[Epub] CrossRef
The safety of perioperative dexamethasone with antiemetic dosage in surgical patients with diabetes mellitus: a systematic review and meta-analysis
Qian-Yun Pang, Jing-Yun Wang, Xiao-Long Liang, Yan Jiang, Hong-Liang Liu
Perioperative Medicine.2023;[Epub] CrossRef
Link between Blood Cell-Associated Inflammatory Indices and Chemotherapy-Induced Hyperglycemia in Women Affected with Breast Cancer: Clinical Studies
Krishna Prasad, Suresh Rao, Sanath Kumar Hegde, Thomas George, Rhea Katherine D'souza, Sucharitha Suresh, Manjeshwar Shrinath Baliga
South Asian Journal of Cancer.2023; 12(02): 118. CrossRef
Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage Breast Cancer
Dana Mahin, Sayeh Moazami Lavasani, Leon Cristobal, Niki Tank Patel, Mina Sedrak, Daphne Stewart, James Waisman, Yuan Yuan, Wai Yu, Raynald Samoa, Nora Ruel, Susan E. Yost, Hayley Lee, Sung Hee Kil, Joanne E. Mortimer
Journal of Clinical Medicine.2023; 12(5): 1906. CrossRef
Oral mometasone furoate administration preserves anti-inflammatory action with fewer metabolic adverse effects in rats
Priscila L. Zimath, Milena S. Almeida, Maciel A. Bruxel, Alex Rafacho
Biochemical Pharmacology.2023; 210: 115486. CrossRef
Regeneration of an infected skin wound under conditions of experimental steroid hyperglycemia
L. A. Balykova, V. I. Inchina, T. V. Tarasova, D. A. Khaydar, L. M. Mosina, I. V. Saushev, A. V. Kuchuk, A. Mutvakel, I. V. Begoulov, R. S. Tarasov, P. V. Ageev, D. S. Ovchenkov
Research and Practical Medicine Journal.2023; 10(1): 90. CrossRef
Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach
Ashok Kumar Das, Banshi Saboo, Rajeev Chawla, S. R. Aravind, Rajesh Rajput, Awadhesh K. Singh, J. J. Mukherjee, Ashok Jhingan, Parag Shah, Vaishali Deshmukh, Shailaja Kale, Shalini Jaggi, G. R. Sridhar, Rajnish Dhediya, Kumar Gaurav
International Journal of Diabetes in Developing Countries.2023; 43(6): 856. CrossRef
Risk for Newly Diagnosed Type 2 Diabetes Mellitus after COVID-19 among Korean Adults: A Nationwide Matched Cohort Study
Jong Han Choi, Kyoung Min Kim, Keeho Song, Gi Hyeon Seo
Endocrinology and Metabolism.2023; 38(2): 245. CrossRef
Zein nanoparticles as oral carrier for mometasone furoate delivery
Priscila Zimath, Soraia Pinto, Sofia Dias, Alex Rafacho, Bruno Sarmento
Drug Delivery and Translational Research.2023; 13(11): 2948. CrossRef
Impact of Diabetes in COVID-19 Associated Mucormycosis and its Management: A Non-Systematic Literature Review
Muhammed Rashid, Asha K. Rajan, Girish Thunga, Vishal Shanbhag, Sreedharan Nair
Current Diabetes Reviews.2023;[Epub] CrossRef
Adrenomedullin Peptides and Precursor Levels in Relation to Haemodynamics and Prognosis After Heart Transplantation
Abdulla Ahmed, Kriss Kania, Hebba Abdul Rahim, Salaheldin Ahmed, Göran Rådegran
ESC Heart Failure.2023; 10(4): 2427. CrossRef
Part II: Interactive case: Drug‐induced endocrine disorders
Amy C. Donihi
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.2023; 6(6): 663. CrossRef
Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?
Riccardo Pofi, Giorgio Caratti, David W Ray, Jeremy W Tomlinson
Endocrine Reviews.2023; 44(6): 975. CrossRef
Disease-modifying anti-rheumatic drugs associated with different diabetes risks in patients with rheumatoid arthritis
Yu-Jih Su, Hui-Ming Chen, Tien-Ming Chan, Tien-Tsai Cheng, Shan-Fu Yu, Jia-Feng Chen, Chun-Yu Lin, Chung-Yuan Hsu
RMD Open.2023; 9(3): e003045. CrossRef
The Prevalence of Diabetes Mellitus Type II (DMII) in the Multiple Sclerosis Population: A Systematic Review and Meta-Analysis
Vasileios Giannopapas, Lina Palaiodimou, Dimitrios Kitsos, Georgia Papagiannopoulou, Konstantina Stavrogianni, Athanasios Chasiotis, Maria Kosmidou, John S. Tzartos, George P. Paraskevas, Daphne Bakalidou, Georgios Tsivgoulis, Sotirios Giannopoulos
Journal of Clinical Medicine.2023; 12(15): 4948. CrossRef
Diabetes Mellitus Secondary to Endocrine Diseases: An Update of Diagnostic and Treatment Particularities
Mihaela Simona Popoviciu, Lorena Paduraru, Raluca Marinela Nutas, Alexandra Maria Ujoc, Galal Yahya, Kamel Metwally, Simona Cavalu
International Journal of Molecular Sciences.2023; 24(16): 12676. CrossRef
The inverse association between DNA gaps and HbA1c levels in type 2 diabetes mellitus
Jirapan Thongsroy, Apiwat Mutirangura
Scientific Reports.2023;[Epub] CrossRef
Corticosteroids for COVID-19: worth it or not?
Fariya Akter, Yusha Araf, Mohammad Jakir Hosen
Molecular Biology Reports.2022; 49(1): 567. CrossRef
Evidence-Based Management of Steroid-Induced Hyperglycemia in the Inpatient Setting
Lauren Longaker, Jennifer N. Clements
ADCES in Practice.2022; 10(1): 40. CrossRef
Is Methylprednisolone Acetate-Related Insulin Resistance Preventable in Cats?
Karine Marchioro Leal, Mariana Barcelos Rocha, Fernanda Venzon Varela, Luana Rodrigues, Priscila Viau Furtado, Fernanda Vieira Amorim da Costa, Álan Gomes Pöppl
Topics in Companion Animal Medicine.2022; 49: 100648. CrossRef
Ac3IV, a V1a and V1b receptor selective vasopressin analogue, protects against hydrocortisone-induced changes in pancreatic islet cell lineage
Shruti Mohan, Ryan A. Lafferty, Peter R. Flatt, R. Charlotte Moffett, Nigel Irwin
Peptides.2022; 152: 170772. CrossRef
Hospital management of hyperglycemia in the context of COVID-19: evidence-based clinical considerations
Thiago Bosco Mendes, Alexandre Barbosa Câmara-de-Souza, Bruno Halpern
Diabetology & Metabolic Syndrome.2022;[Epub] CrossRef
When therapeutic drugs lead to diabetes
Bruno Fève, André J. Scheen
Diabetologia.2022; 65(5): 751. CrossRef
Nutrition implications of intrinsic restrictive lung disease
Sylvia Rinaldi, Christine Balsillie, Cassandra Truchon, Awatif AL‐Mubarak, Marco Mura, Janet Madill
Nutrition in Clinical Practice.2022; 37(2): 239. CrossRef
Coinfection by Aspergillus and Mucoraceae Species in Two Cases of Acute Rhinosinusitis as a Complication of COVID-19
Payam Tabarsi, Somayeh Sharifynia, Mihan Pourabdollah Toutkaboni, Zahra Abtahian, Mohammad Rahdar, Arefeh Sadat Mirahmadian, Atousa Hakamifard, Simone Cesaro
Case Reports in Medicine.2022; 2022: 1. CrossRef
Case Report: Neratinib Therapy Improves Glycemic Control in a Patient With Type 2 Diabetes and Breast Cancer
Vasileios Angelis, Stephen R. D. Johnston, Amin Ardestani, Kathrin Maedler
Frontiers in Endocrinology.2022;[Epub] CrossRef
The Impact of Deranged Glucose Metabolism and Diabetes in the Pathogenesis and Prognosis of the Novel SARS-CoV-2: A Systematic Review of Literature
Victor O. Ukwenya, Sunday A. Adelakun, Temiloluwa A. Fuwape, Ayotunde S. Adeagbo
Current Diabetes Reviews.2022;[Epub] CrossRef
Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?
Rahul Gupta
Bulletin of the National Research Centre.2022;[Epub] CrossRef
Circadian clock, diurnal glucose metabolic rhythm, and dawn phenomenon
Fei Peng, Xin Li, Fang Xiao, Ruxing Zhao, Zheng Sun
Trends in Neurosciences.2022; 45(6): 471. CrossRef
3,3′,4,5′-Tetramethoxy-trans-stilbene Improves Insulin Resistance by Activating the IRS/PI3K/Akt Pathway and Inhibiting Oxidative Stress
Yi Tan, Lingchao Miao, Jianbo Xiao, Wai San Cheang
Current Issues in Molecular Biology.2022; 44(5): 2175. CrossRef
Management of Glucocorticoid-Induced Hyperglycemia
Parag Shah, Sanjay Kalra, Yogesh Yadav, Nilakshi Deka, Tejal Lathia, Jubbin Jagan Jacob, Sunil Kumar Kota, Saptarshi Bhattacharya, Sharvil S Gadve, KAV Subramanium, Joe George, Vageesh Iyer, Sujit Chandratreya, Pankaj Kumar Aggrawal, Shailendra Kumar Sing
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1577. CrossRef
Effects of glucocorticoids on interstitial glucose concentrations in individuals with hematologic cancer and without known diagnosis of diabetes: a pilot study
Marcos Tadashi Kakitani Toyoshima, Priscilla Cukier, Alexandre Barbosa Câmara de Souza, Juliana Pereira, Ana Oliveira Hoff, Marcia Nery
einstein (São Paulo).2022;[Epub] CrossRef
Mucormycosis in the COVID-19 Environment: A Multifaceted Complication
Rohit Sharma, Praveen Kumar, Abdur Rauf, Ashun Chaudhary, Pradeep Kumar Prajapati, Talha Bin Emran, Clara Mariana Gonçalves Lima, Carlos Adam Conte-Junior
Frontiers in Cellular and Infection Microbiology.2022;[Epub] CrossRef
Black pepper oil (Piper nigrum L.) mitigates dexamethasone induced pancreatic damage via modulation of oxidative and nitrosative stress
Mona F. Mahmoud, Asmaa M. Elmaghraby, Noura Ali, Islam Mostafa, Assem M. El-Shazly, Mohamed A.O. Abdelfattah, Mansour Sobeh
Biomedicine & Pharmacotherapy.2022; 153: 113456. CrossRef
Various Coated Barrier Membranes for Better Guided Bone Regeneration: A Review
Ji-Youn Kim, Jun-Beom Park
Coatings.2022; 12(8): 1059. CrossRef
RETROSPECTIVE STUDY ON GLYCAEMIC CONTROL OF THE MIDDLE-AGED PATIENTS RECEIVING STEROID THERAPY IN COVID ICU
Sayantan Dutta, Sumanta Ghosh Maulik, Jisnu Nayak
PARIPEX INDIAN JOURNAL OF RESEARCH.2022; : 1. CrossRef
Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy
Joachim Baech, Marianne Tang Severinsen, Andreas K. Øvlisen, Henrik Frederiksen, Peter Vestergaard, Christian Torp-Pedersen, Judit Jørgensen, Michael Roost Clausen, Christian B. Poulsen, Peter Brown, Anne Ortved Gang, Robert Schou Pedersen, Karin Ekström
Blood Advances.2022; 6(15): 4427. CrossRef
Diabètes pharmaco-induits : quatre classes médicamenteuses au cœur de notre pratique clinique
André J. Scheen, Bruno Fève
Médecine des Maladies Métaboliques.2022; 16(7): 627. CrossRef
Dexamethasone-Induced Derangement in Some Liver Function Parameters
Timothy Danboyi, Abdulazeez Jimoh, Evelyn Hassan-Danboyi, Abdul Wahab Alhassan, Augustine Banlibo Dubo
Nigerian Journal of Experimental and Clinical Biosciences.2022; 10(3): 74. CrossRef
Polypharmacy Patterns in Multimorbid Older People with Cardiovascular Disease: Longitudinal Study
Noemí Villén, Albert Roso-Llorach, Carlos Gallego-Moll, Marc Danes-Castells, Sergio Fernández-Bertolin, Amelia Troncoso-Mariño, Monica Monteagudo, Ester Amado, Concepción Violán
Geriatrics.2022; 7(6): 141. CrossRef
Increased risk of type 2 diabetes in patients with systemic lupus erythematosus: A nationwide cohort study in Taiwan
Yeong-Jang Lin, Chih-Chiang Chien, Chung-Han Ho, Hung-An Chen, Chao-Yu Chen
Medicine.2022; 101(51): e32520. CrossRef
Synthetic Pharmacotherapy for Systemic Lupus Erythematosus: Potential Mechanisms of Action, Efficacy, and Safety
Angélica María Téllez Arévalo, Abraham Quaye, Luis Carlos Rojas-Rodríguez, Brian D. Poole, Daniela Baracaldo-Santamaría, Claudia M. Tellez Freitas
Medicina.2022; 59(1): 56. CrossRef
Effect of Ficus lacor Buch. Ham. Fruit Extract on Dexamethasone Induced Insulin Resistant Rats
V. S. Mule, N. S. Naikwade
Research Journal of Pharmacy and Technology.2022; : 5559. CrossRef
Prednisolone-induced diabetes mellitus in the cat: a historical cohort
Sivert Nerhagen, Hanne L Moberg, Gudrun S Boge, Barbara Glanemann
Journal of Feline Medicine and Surgery.2021; 23(2): 175. CrossRef
A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes
Thomas Forst, Pratik Choudhary, Doron Schneider, Bruno Linetzky, Paolo Pozzilli
Diabetes/Metabolism Research and Reviews.2021;[Epub] CrossRef
Incidence and control of steroid-induced hyperglycaemia in hospitalised patients at a tertiary care centre for lung diseases
Matej Dobravc Verbič, Jasna Gruban, Mojca Kerec Kos
Pharmacological Reports.2021; 73(3): 796. CrossRef
Epigenetics in blood–brain barrier disruption
Stephanie A. Ihezie, Iny Elizebeth Mathew, Devin W. McBride, Ari Dienel, Spiros L. Blackburn, Peeyush Kumar Thankamani Pandit
Fluids and Barriers of the CNS.2021;[Epub] CrossRef
Risk factors for corticosteroid-induced hyperglycemia requiring insulin therapy in hospitalized patients without diabetes
Catherine Li, Patricia Krause, Gretchen Stern
Endocrine.2021; 73(2): 476. CrossRef
Population pharmacodynamic modeling of intramuscular and oral dexamethasone and betamethasone effects on six biomarkers with circadian complexities in Indian women
Wojciech Krzyzanski, Mark A. Milad, Alan H. Jobe, Thomas Peppard, Robert R. Bies, William J. Jusko
Journal of Pharmacokinetics and Pharmacodynamics.2021; 48(3): 411. CrossRef
Hormonal activity in commonly used Black hair care products: evaluating hormone disruption as a plausible contribution to health disparities
Tamarra James-Todd, Lisa Connolly, Emma V. Preston, Marlee R. Quinn, Monika Plotan, Yuling Xie, Bharathi Gandi, Shruthi Mahalingaiah
Journal of Exposure Science & Environmental Epidemiology.2021; 31(3): 476. CrossRef
New‐onset diabetes in “long COVID”
Thirunavukkarasu Sathish, Mary Chandrika Anton, Tharsan Sivakumar
Journal of Diabetes.2021; 13(8): 693. CrossRef
Glucocorticoid-Induced Exacerbation of Mycobacterial Infection Is Associated With a Reduced Phagocytic Capacity of Macrophages
Yufei Xie, Jiajun Xie, Annemarie H. Meijer, Marcel J. M. Schaaf
Frontiers in Immunology.2021;[Epub] CrossRef
Glucocorticoid signaling in pancreatic islets modulates gene regulatory programs and genetic risk of type 2 diabetes
Anthony Aylward, Mei-Lin Okino, Paola Benaglio, Joshua Chiou, Elisha Beebe, Jose Andres Padilla, Sharlene Diep, Kyle J. Gaulton, Michael L. Stitzel
PLOS Genetics.2021; 17(5): e1009531. CrossRef
A Practical Guide for the Management of Steroid Induced Hyperglycaemia in the Hospital
Felix Aberer, Daniel A. Hochfellner, Harald Sourij, Julia K. Mader
Journal of Clinical Medicine.2021; 10(10): 2154. CrossRef
Combination of Bawang Dayak Extract and Acarbose against Male White Rat Glucose Levels
Aditya Maulana Perdana Putra, Ratih Pratiwi Sari, Siska Musiam
Borneo Journal of Pharmacy.2021; 4(2): 84. CrossRef
Role of Gliclazide in safely navigating type 2 diabetes mellitus patients towards euglycemia: Expert opinion from India
Subhash Wangnoo, M. Shunmugavelu, Sagili Vijaya Bhaskar Reddy, Vijay Negalur, Shreerang Godbole, Vinay K Dhandhania, Nareen Krishna, Kumar Gaurav
Endocrine and Metabolic Science.2021; 4: 100102. CrossRef
Genome-Wide Differential Methylation Profiles from Two Terpene-Rich Medicinal Plant Extracts Administered in Osteoarthritis Rats
Younhee Shin, Sathiyamoorthy Subramaniyam, Jin-Mi Chun, Ji-Hyeon Jeon, Ji-Man Hong, Hojin Jung, Boseok Seong, Chul Kim
Plants.2021; 10(6): 1132. CrossRef
Chronic glucocorticoid treatment induces hepatic lipid accumulation and hyperinsulinaemia in part through actions on AgRP neurons
Erika Harno, Charlotte Sefton, Jonathan R. Wray, Tiffany-Jayne Allen, Alison Davies, Anthony P. Coll, Anne White
Scientific Reports.2021;[Epub] CrossRef
Endocrine Disorders in Autoimmune Rheumatological Diseases: A Focus on Thyroid Autoimmune Diseases and on the Effects of Chronic Glucocorticoid Treatment
Filippo Egalini, Mirko Parasiliti Caprino, Giulia Gaggero, Vincenzo Cappiello, Jacopo Giannelli, Ruth Rossetto Giaccherino, Loredana Pagano, Roberta Giordano
Endocrines.2021; 2(3): 171. CrossRef
Current cancer therapies and their influence on glucose control
Carly Yim, Kerry Mansell, Nassrein Hussein, Terra Arnason
World Journal of Diabetes.2021; 12(7): 1010. CrossRef
Immune‐checkpoint inhibitor‐associated diabetes compared to other diabetes types ‐ A prospective, matched control study
Sascha R. Tittel, Katharina Laubner, Sebastian M. Schmid, Stefan Kress, Sigrun Merger, Wolfram Karges, Frank J. Wosch, Marcus Altmeier, Marianne Pavel, Reinhard W. Holl
Journal of Diabetes.2021; 13(12): 1007. CrossRef
Connecting the Dots: Interplay of Pathogenic Mechanisms between COVID-19 Disease and Mucormycosis
Hariprasath Prakash, Anna Skiada, Raees Ahmad Paul, Arunaloke Chakrabarti, Shivaprakash Mandya Rudramurthy
Journal of Fungi.2021; 7(8): 616. CrossRef
Antioxidant Effects of L-citrulline Supplementation in High-fat Diet- and Dexamethasone-induced Type-2 Diabetes Mellitus in Wistar Rats (Rattus norvegicus)
Evelyn Hassan-Danboyi, Abdulazeez Jimoh, Abdulwahab Alhassan, Timothy Danboyi, Kabir Ahmed Mohammed, Augustine Banlibo Dubo, Jamilu Haruna, Bulus Billy Yakubu
Nigerian Journal of Experimental and Clinical Biosciences.2021; 9(2): 95. CrossRef
ASSESSMENT OF THE POSSIBLE CAUSES OF DIABETES MELLITUS DEVELOPED IN PATIENTS POST COVID-19 TREATMENT IN A TERTIARY CARE HOSPITAL
KHUJITH RAJUENI, RUTUJA AMBEKAR, HITENDRAPAL SOLANKI, ABDULRAHAMAN ABUBAKAR MOMIN, SUNITA PAWAR
International Journal of Pharmacy and Pharmaceutical Sciences.2021; : 11. CrossRef
Potent Anti-Inflammatory, Arylpyrazole-Based Glucocorticoid Receptor Agonists That Do Not Impair Insulin Secretion
Brandon J. Kennedy, Ashley M. Lato, Alexander R. Fisch, Susan J. Burke, Justin K. Kirkland, Carson W. Prevatte, Lee E. Dunlap, Russell T. Smith, Konstantinos D. Vogiatzis, J. Jason Collier, Shawn R. Campagna
ACS Medicinal Chemistry Letters.2021; 12(10): 1568. CrossRef
Diabetes in COVID-19 patients: challenges and possible management strategies
Riyan Al Islam Reshad, Sumaiya Hafiz Riana, Mohammad Al-baruni Chowdhury, Abu Tayab Moin, Faruque Miah, Bishajit Sarkar, Nurnabi Azad Jewel
The Egyptian Journal of Bronchology.2021;[Epub] CrossRef
Excess Body Mass—A Factor Leading to the Deterioration of COVID-19 and Its Complications—A Narrative Review
Weronika Gryczyńska, Nikita Litvinov, Bezawit Bitew, Zuzanna Bartosz, Weronika Kośmider, Paweł Bogdański, Damian Skrypnik
Viruses.2021; 13(12): 2427. CrossRef
Molecular mechanism of glucocorticoid-induced hyperglycemia
Destika Ambar Sari, Galih Samodra, Ikhwan Yuda Kusuma
Pharmacy Reports.2021; 1(1): 1. CrossRef
Risk of Future Type 2 Diabetes Mellitus in Patients Developing Steroid-Induced Hyperglycemia During Hospitalization for Chronic Obstructive Pulmonary Disease Exacerbation
Jagriti Upadhyay, Nitin Trivedi, Amos Lal
Lung.2020; 198(3): 525. CrossRef
Acetylation of Hsp90 reverses dexamethasone-mediated inhibition of insulin secretion
Kecheng Zhu, Yumei Zhang, Juan Zhang, Feiye Zhou, Linlin Zhang, Shushu Wang, Qin Zhu, Qianqian Liu, Xiao Wang, Libin Zhou
Toxicology Letters.2020; 320: 19. CrossRef
Use of inhaled corticosteroids and the risk of developing type 2 diabetes in patients with chronic obstructive pulmonary disease
Mohamad Isam Saeed, Josefin Eklöf, Imane Achir, Pradeesh Sivapalan, Howraman Meteran, Anders Løkke, Tor Biering‐Sørensen, Filip Krag Knop, Jens‐Ulrik Stæhr Jensen
Diabetes, Obesity and Metabolism.2020; 22(8): 1348. CrossRef
Patterns of Glucose Fluctuation are Challenging in Patients Treated for Non-Hodgkin’s Lymphoma

Andreja Marić, Tanja Miličević, Jelena Vučak Lončar, Davor Galušić, Maja Radman
International Journal of General Medicine.2020; Volume 13: 131. CrossRef
Metformin's effectiveness in preventing prednisone-induced hyperglycemia in hematological cancers
Lucy A Ochola, David G Nyamu, Eric M Guantai, Irene W Weru
Journal of Oncology Pharmacy Practice.2020; 26(4): 823. CrossRef
Study rationale and design of the EANITIATE study (EmpAgliflozin compared to NPH Insulin for sTeroId diAbeTEs) - a randomized, controlled, multicenter trial of safety and efficacy of treatment with empagliflozin compared with NPH-insulin in patients with
Carina Kirstine Klarskov, Helga Holm Schultz, Frederik Persson, Tomas Møller Christensen, Thomas Peter Almdal, Ole Snorgaard, Katrine Bagge Hansen, Ulrik Pedersen-Bjergaard, Peter Lommer Kristensen
BMC Endocrine Disorders.2020;[Epub] CrossRef
Implementation of a Weight-Based Protocol for the Management of Steroid-Induced Hyperglycemia
Alyson K. Myers, Mahmuda Khan, Sebastian Choi, Patricia Garnica, Guillaume Stoffels, Amanda Lin
American Journal of Therapeutics.2020; 27(4): e392. CrossRef
The difference between steroid diabetes mellitus and type 2 diabetes mellitus: a whole-body 18F-FDG PET/CT study
Qingqing Zhao, Jinxin Zhou, Yu Pan, Huijun Ju, Liying Zhu, Yang Liu, Yifan Zhang
Acta Diabetologica.2020; 57(11): 1383. CrossRef
Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis
Jianhua Wu, Sarah L Mackie, Mar Pujades-Rodriguez
BMJ Open Diabetes Research & Care.2020; 8(1): e001220. CrossRef
Diabète et corticoïdes : nouveautés et aspects pratiques
M. Bastin, F. Andreelli
La Revue de Médecine Interne.2020; 41(9): 607. CrossRef
Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes
Janine Alessi, Giovana B. de Oliveira, Beatriz D. Schaan, Gabriela H. Telo
Diabetology & Metabolic Syndrome.2020;[Epub] CrossRef
Mechanisms and Clinical Applications of Glucocorticoid Steroids in Muscular Dystrophy
Mattia Quattrocelli, Aaron S. Zelikovich, Isabella M. Salamone, Julie A. Fischer, Elizabeth M. McNally
Journal of Neuromuscular Diseases.2020; 8(1): 39. CrossRef
Glycemic Response to Oral Dexamethasone Predicts Incident Prediabetes in Normoglycemic Subjects With Parental Diabetes
Ebenezer Nyenwe, Deirdre James, Jim Wan, Sam Dagogo-Jack
Journal of the Endocrine Society.2020;[Epub] CrossRef
Outcomes of Hospitalized Patients with Glucocorticoid-Induced Hyperglycemia—A Retrospective Analysis
Neele Delfs, Tristan Struja, Sandra Gafner, Thaddaeus Muri, Ciril Baechli, Philipp Schuetz, Beat Mueller, Claudine Angela Blum
Journal of Clinical Medicine.2020; 9(12): 4079. CrossRef
Incidence of Hyperglycemia/Secondary Diabetes in Women who have Undergone Curative Chemotherapy for Breast Cancer: First Study from India
Suresh Rao, Krishna Prasad, Soniya Abraham, Thomas George, Supreeth Kakkaje Chandran, Manjeshwar Shrinath Baliga
South Asian Journal of Cancer.2020; 09(03): 130. CrossRef
Analysis of the Potential Association of Drug-Metabolizing Enzymes CYP2C9*3 and CYP2C19*3 Gene Variations With Type 2 Diabetes: A Case-Control Study
Imadeldin Elfaki, Rashid Mir, Faisel Mohammed Abu-Duhier, Chandan Kumar Jha, Adel Ibrahim Ahmad Al-Alawy, Abdullatif Taha Babakr, Salem Abd El-Hadi Habib
Current Drug Metabolism.2020; 21(14): 1152. CrossRef
What is the optimal time for measuring glucose concentration to detect steroid-induced hyperglycemia in patients with rheumatic diseases?
Güven Barış Cansu, Döndü Üsküdar Cansu, Bengür Taşkıran, Şule Yaşar Bilge, Muzaffer Bilgin, Cengiz Korkmaz
Clinical Biochemistry.2019; 67: 33. CrossRef
Risedronate Attenuates Podocyte Injury in Phosphate Transporter-Overexpressing Rats
Yohei Asada, Takeshi Takayanagi, Tsukasa Kawakami, Eisuke Tomatsu, Atsushi Masuda, Yasumasa Yoshino, Sahoko Sekiguchi-Ueda, Megumi Shibata, Tomihiko Ide, Hajime Niimi, Eishin Yaoita, Yusuke Seino, Yoshihisa Sugimura, Atsushi Suzuki
International Journal of Endocrinology.2019; 2019: 1. CrossRef
Novel aspects of PCSK9 and lipoprotein receptors in renal disease-related dyslipidemia
Pragyi Shrestha, Bart van de Sluis, Robin P.F. Dullaart, Jacob van den Born
Cellular Signalling.2019; 55: 53. CrossRef
Understanding the burden of refractory myasthenia gravis
Christiane Schneider-Gold, Tim Hagenacker, Nico Melzer, Tobias Ruck
Therapeutic Advances in Neurological Disorders.2019;[Epub] CrossRef
Drug-induced diabetes type 2: In silico study involving class B GPCRs
Dorota Latek, Ewelina Rutkowska, Szymon Niewieczerzal, Judyta Cielecka-Piontek, Arun Shukla
PLOS ONE.2019; 14(1): e0208892. CrossRef
Periodically repeated rituximab administrations in children with refractory nephrotic syndrome: 2-year multicenter observational study
Toshiyuki Takahashi, Takayuki Okamoto, Yasuyuki Sato, Takeshi Yamazaki, Asako Hayashi, Hayato Aoyagi, Michihiko Ueno, Norio Kobayashi, Kimiaki Uetake, Masanori Nakanishi, Tadashi Ariga
Pediatric Nephrology.2019; 34(1): 87. CrossRef
Management of hyperglycaemia in persons with non-insulin-dependent type 2 diabetes mellitus who are started on systemic glucocorticoid therapy: a systematic review
Milos Tatalovic, Roger Lehmann, Marcus Cheetham, Albina Nowak, Edouard Battegay, Silvana K Rampini
BMJ Open.2019; 9(5): e028914. CrossRef
The effect of diabetes mellitus on in-hospital hyperglycemia, length of stay and survival in patients with brain tumor receiving dexamethasone: A descriptive and comparative analysis
Panteleimon Pantelidis, Parmenion P. Tsitsopoulos, Eleni Pappa, Elpida Theologou, Nikolaos Karanikolas, Christos Drosos, Christos Tsonidis
Clinical Neurology and Neurosurgery.2019; 184: 105450. CrossRef
Impact of glucocorticoid treatment before pregnancy on glucose homeostasis of offspring exposed to glucocorticoid in adult life
Flávia Natividade da Silva, Henver Simionato Brunetta, Maciel Alencar Bruxel, Felipe Azevedo Gomes, Alex Rafacho
Life Sciences.2019; 237: 116913. CrossRef
One week of continuous corticosterone exposure impairs hepatic metabolic flexibility, promotes islet β-cell proliferation, and reduces physical activity in male C57BL/6 J mice
Susan J. Burke, Heidi M. Batdorf, Tai-Yu Huang, Joseph W. Jackson, Katarina A. Jones, Thomas M. Martin, Kristen E. Rohli, Michael D. Karlstad, Tim E. Sparer, David H. Burk, Shawn R. Campagna, Robert C. Noland, Paul L. Soto, J. Jason Collier
The Journal of Steroid Biochemistry and Molecular Biology.2019; 195: 105468. CrossRef
Effect of preadmission glucocorticoid therapy on 30-day mortality in critically ill patients: a retrospective study of a mixed ICU population in a tertiary hospital
Tak Kyu Oh, In-Ae Song, Jae Ho Lee, Cheong Lim, Young-Tae Jeon, Hee-Joon Bae, You Hwan Jo
Annals of Intensive Care.2019;[Epub] CrossRef
Hospitalization as an Opportunity to Optimize Glycemic Control in Oncology Patients
Amy Hiestand, James Flory, Ritika Chitkara
Current Diabetes Reports.2019;[Epub] CrossRef
Corticothérapie prolongée chez une personne âgée et diabète
J.L. Schlienger
Médecine des Maladies Métaboliques.2018; 12(7): 599. CrossRef
Activation of nuclear receptor PXR impairs glucose tolerance and dysregulates GLUT2 expression and subcellular localization in liver
Fatemeh Hassani-Nezhad-Gashti, Jaana Rysä, Outi Kummu, Juha Näpänkangas, Marcin Buler, Mikko Karpale, Janne Hukkanen, Jukka Hakkola
Biochemical Pharmacology.2018; 148: 253. CrossRef
Diabetes Mellitus Secondary to Cushing’s Disease
Mattia Barbot, Filippo Ceccato, Carla Scaroni
Frontiers in Endocrinology.2018;[Epub] CrossRef
MANAGEMENT OF ENDOCRINE DISEASE: Critical review of the evidence underlying management of glucocorticoid-induced hyperglycaemia
Anjana Radhakutty, Morton G Burt
European Journal of Endocrinology.2018; 179(4): R207. CrossRef
Use of parenteral glucocorticoids and the risk of new onset type 2 diabetes mellitus: A case-control study
Ala Keyany, Johannes T.H. Nielen, Patrick C. Souverein, Frank de Vries, Bart van den Bemt
Diabetes Research and Clinical Practice.2018; 139: 100. CrossRef
Dominance of the hypothalamus-pituitary-adrenal axis over the renin-angiotensin-aldosterone system is a risk factor for decreased insulin secretion
Makoto Daimon, Aya Kamba, Hiroshi Murakami, Satoru Mizushiri, Sho Osonoi, Kota Matsuki, Eri Sato, Jutaro Tanabe, Shinobu Takayasu, Yuki Matsuhashi, Miyuki Yanagimachi, Ken Terui, Kazunori Kageyama, Itoyo Tokuda, Shizuka Kurauchi, Shigeyuki Nakaji
Scientific Reports.2017;[Epub] CrossRef

Original Article

Clinical Study
Recovery of Adrenal Function in Patients with Glucocorticoids Induced Secondary Adrenal Insufficiency: Jong Ha Baek, Soo Kyoung Kim, Jung Hwa Jung, Jong Ryeal Hahm, Jaehoon Jung; Endocrinol Metab. 2016;31(1):153-160. Published online March 16, 2016; DOI: https://doi.org/10.3803/EnM.2016.31.1.153

11,448 View
138 Download
13 Web of Science
14 Crossref

Abstract PDF PubReader

Background

The chronic use of glucocorticoids (GC) suppresses function of the hypothalamic-pituitary-adrenal axis and often results in secondary adrenal insufficiency (AI). The present study aimed to determine the recovery rate of adrenal function in patients with secondary AI within 1 to 2 years and to assess the factors predictive of adrenal function recovery.

Methods

This was a retrospective observational study that enrolled patients diagnosed with GC-induced secondary AI between 2007 and 2013. AI was defined by peak serum cortisol levels <18 µg/dL during a standard-dose short synacthen test (SST). A follow-up SST was performed after 1 to 2 years, and responders were defined as those with adrenocorticotropic hormone (ACTH)-stimulated peak serum cortisol levels ≥18 µg/dL.

Results

Of the total 34 patients diagnosed with GC-induced secondary AI at first, 20 patients (58.8%) recovered normal adrenal function by the time of the follow-up SST (median follow-up period, 16.5 months). Although the baseline serum ACTH and cortisol levels at the first SST did not differ between responders and non-responders, the incremental cortisol response during the first SST was higher in responders than that of non-responders (7.88 vs. 3.56, P<0.01). Additionally, higher cortisol increments during the first SST were an independent predictive factor of the adrenal function recovery (odds ratio, 1.58; 95% confidence interval, 1.02 to 2.46; P<0.05).

Conclusion

In the present study, adrenal function recovery was achieved frequently in patients with GC-induced secondary AI within 1 to 2 years. Additionally, an incremental cortisol response at the first SST may be an important predictive factor of adrenal function recovery.

Citations

Citations to this article as recorded by

Unintentional dexamethasone and steroid abuse among Yemeni patients: a case series
Butheinah A. Al-Sharafi
Journal of Clinical and Translational Endocrinology: Case Reports.2025; 37: 100198. CrossRef
European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency
Felix Beuschlein, Tobias Else, Irina Bancos, Stefanie Hahner, Oksana Hamidi, Leonie van Hulsteijn, Eystein S Husebye, Niki Karavitaki, Alessandro Prete, Anand Vaidya, Christine Yedinak, Olaf M Dekkers
European Journal of Endocrinology.2024; 190(5): G25. CrossRef
European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency
Felix Beuschlein, Tobias Else, Irina Bancos, Stefanie Hahner, Oksana Hamidi, Leonie van Hulsteijn, Eystein S Husebye, Niki Karavitaki, Alessandro Prete, Anand Vaidya, Christine Yedinak, Olaf M Dekkers
The Journal of Clinical Endocrinology & Metabolism.2024; 109(7): 1657. CrossRef
Safely Withdrawing Glucocorticoid Therapy: A Case-Based Approach
Mohammed Alenazi, Khaled Aldahmani, Syed Ali Imran
Journal of Diabetes and Endocrine Practice.2024; 07(03): 129. CrossRef
Secondary Adrenal Insufficiency: Recent Updates and New Directions for Diagnosis and Management
Lucinda M. Gruber, Irina Bancos
Endocrine Practice.2022; 28(1): 110. CrossRef
Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study
Andrew Menzies-Gow, Mark Gurnell, Liam G Heaney, Jonathan Corren, Elisabeth H Bel, Jorge Maspero, Timothy Harrison, David J Jackson, David Price, Njira Lugogo, James Kreindler, Annie Burden, Alex de Giorgio-Miller, Kelly Padilla, Ubaldo J Martin, Esther G
The Lancet Respiratory Medicine.2022; 10(1): 47. CrossRef
Development and Resolution of Secondary Adrenal Insufficiency after an Intra-Articular Steroid Injection
Jia Wei Tan, Sachin K. Majumdar, Osamu Isozaki
Case Reports in Endocrinology.2022; 2022: 1. CrossRef
Long‐term corticosteroid use, adrenal insufficiency and the need for steroid‐sparing treatment in adult severe asthma
M. Gurnell, L. G. Heaney, D. Price, A. Menzies‐Gow
Journal of Internal Medicine.2021; 290(2): 240. CrossRef
Glucocorticoid Withdrawal—An Overview on When and How to Diagnose Adrenal Insufficiency in Clinical Practice
Katarzyna Pelewicz, Piotr Miśkiewicz
Diagnostics.2021; 11(4): 728. CrossRef
Morning Serum Cortisol as a Predictor for the HPA Axis Recovery in Cushing’s Disease
Q. Cui, D. Liu, B. Xiang, Q. Sun, L. Fan, M. He, Y. Wang, X. Zhu, H. Ye, Giorgio Borretta
International Journal of Endocrinology.2021; 2021: 1. CrossRef
Dexamethasone-related adrenal insufficiency in patients with brain and skull base tumours
H. Benghiat, P. Sanghera, D. Stange, P. Nightingale, A. Hartley, M.W O’Reilly, N. Nundall, H. Currie, M. Ali, G. Cruickshank, D. Spooner, A. Toogood
Supportive Care in Cancer.2018; 26(12): 4031. CrossRef
Articles inEndocrinology and Metabolismin 2016
Won-Young Lee
Endocrinology and Metabolism.2017; 32(1): 62. CrossRef
The unresolved riddle of glucocorticoid withdrawal
F. Guerrero Pérez, A. P. Marengo, C. Villabona Artero
Journal of Endocrinological Investigation.2017; 40(11): 1175. CrossRef
Lessons from iatrogenic Cushing syndrome in children
Betty P Messazos, Margaret R Zacharin
Journal of Paediatrics and Child Health.2016; 52(12): 1106. CrossRef

Case Reports

Thyroid
Steroid Responsive Xanthomatous Hypophysitis Associated with Autoimmune Thyroiditis: A Case Report: Ji Young Joung, Hyemin Jeong, Yoon Young Cho, Kyoungmin Huh, Yeon-Lim Suh, Kwang-Won Kim, Ji Cheol Bae; Endocrinol Metab. 2013;28(1):65-69. Published online March 25, 2013; DOI: https://doi.org/10.3803/EnM.2013.28.1.65

6,319 View
34 Download
16 Crossref

Abstract PDF PubReader

We report the case of a 36-year-old woman who presented with headache, fever, and amenorrhea. Laboratory analysis revealed hypopituitarism and autoimmune thyroiditis, while a cerebrospinal fluid study suggested concurrent aseptic meningitis. A magnetic resonance image (MRI) scan revealed a 1.0×0.9 cm cystic mass enlarging the sella turcica. Surgical resection via an endoscopic transsphenoidal route was performed. The histological finding of the excised tissue revealed foamy histiocytes with vacuolated cytoplasm, supporting the diagnosis of xanthomatous hypophysitis. Although a residual soft lesion was observed on the MRI image postoperatively, the patient's headache and fever improved. Ten months after surgery, the patient complained of visual impairment and headache, and the residual mass had enlarged into the suprasellar area. High dose (500 mg intravenous) methylprednisolone was administered for 3 days. During the methylprednisolone pulse therapy, the patient's visual acuity and headache improved. A follow-up MRI taken after methylprednisolone therapy showed a marked mass reduction. Our case supports an autoimmune pathophysiology for xanthomatous hypophysitis and suggests that high dose glucocorticoid therapy as a treatment option.

Citations

Citations to this article as recorded by

Xanthomatous hypophysitis causing hypogonadotropic hypogonadism resulting in delayed presentation of slipped capital femoral epiphysis
Kirit Singh, Avinash Kumar Kanodia, Peter Ross, Antonia Torgersen, Jamie Maclean, Graham Leese, Kismet Hossain-Ibrahim
British Journal of Neurosurgery.2022; 36(2): 286. CrossRef
Full recovery from chronic headache and hypopituitarism caused by lymphocytic hypophysitis: A case report
Mao-Guang Yang, Han-Qing Cai, Si-Si Wang, Lin Liu, Chun-Mei Wang
World Journal of Clinical Cases.2022; 10(3): 1041. CrossRef
Xanthomatous Hypophysitis Secondary to a Ruptured Rathke’s Cleft Cyst: A Case Report
Emre Gezer, Burak Çabuk, Büşra Yaprak Bayrak, Zeynep Cantürk, Berrin Çetinarslan, Alev Selek, Mehmet Sözen, Damla Köksalan, Savaş Ceylan
Brain Tumor Research and Treatment.2022; 10(1): 48. CrossRef
Successful immunomodulatory treatment for recurrent xanthogranulomatous hypophysitis in an adolescent: illustrative case
Sarah DeCou, Pablo F. Recinos, Richard A. Prayson, Christopher Karakasis, Anzar Haider, Neha Patel
Journal of Neurosurgery: Case Lessons.2022;[Epub] CrossRef
Xanthogranulomatous hypophysitis: A rare presentation in a young female patient
Mohammad Ali Yaghoubi, Samira Zabihyan, Amin Saeidinia, Masoumeh Gharib, Ramin Ghiyasi Moghaddam
Clinical Case Reports.2022;[Epub] CrossRef
Xanthomatous Hypophysitis Presenting in an Adolescent Girl: A Long-Term Follow-Up of a Rare Case and Review of the Literature
Jeanne Sze Lyn Wong, Azraai Bahari Nasruddin, Nalini M. Selveindran, Kartikasalwah Abd Latif, Fauziah Kassim, Sukanya Banerjee Nair, Janet Y.H. Hong
AACE Clinical Case Reports.2021; 7(3): 220. CrossRef
Xanthomatous Hypophysitis: A Case Report and Comprehensive Literature Review
Jianyu Zhu, Zhicheng Wang, Wenze Wang, Jinghua Fan, Yi Zhang, Xiaoxu Li, Jie Liu, Shenzhong Jiang, Kan Deng, Lian Duan, Yong Yao, Huijuan Zhu
Frontiers in Endocrinology.2021;[Epub] CrossRef
Recurring Primary Xanthomatous Hypophysitis Behaving Like Pituitary Adenoma: Additional Case and Literature Review
Mansour Mathkour, Tyler Zeoli, Cassidy Werner, Tyler Scullen, Juanita Garces, Joseph Keen, Marcus Ware
World Neurosurgery.2020; 138: 27. CrossRef
Imaging findings in hypophysitis: a review
Ferdinando Caranci, Giuseppe Leone, Andrea Ponsiglione, Massimo Muto, Fabio Tortora, Mario Muto, Sossio Cirillo, Luca Brunese, Alfonso Cerase
La radiologia medica.2020; 125(3): 319. CrossRef
Hypophysitis in the era of immune checkpoint inhibitors and immunoglobulin G4-related disease
Leen Wehbeh, Sama Alreddawi, Roberto Salvatori
Expert Review of Endocrinology & Metabolism.2019; 14(3): 167. CrossRef
Xanthomatous Hypophysitis Is Associated with Ruptured Rathke’s Cleft Cyst
Kai Duan, Sylvia L. Asa, Daniel Winer, Zadeh Gelareh, Fred Gentili, Ozgur Mete
Endocrine Pathology.2017; 28(1): 83. CrossRef
Xanthomatous Hypophysitis Presenting with Diabetes Insipidus Completely Cured Through Transsphenoidal Surgery: Case Report and Literature Review
Wei Lin, Lu Gao, Xiaopeng Guo, Wenze Wang, Bing Xing
World Neurosurgery.2017; 104: 1051.e7. CrossRef
Review of xanthomatous lesions of the sella
B.K. Kleinschmidt‐DeMasters, Kevin O. Lillehei, Todd C. Hankinson
Brain Pathology.2017; 27(3): 377. CrossRef
Xanthomatous hypophysitis
Bishoy Hanna, Yan M. Li, Timothy Beutler, Parul Goyal, Walter A. Hall
Journal of Clinical Neuroscience.2015; 22(7): 1091. CrossRef
Clinical Characteristics, Management, and Outcome of 22 Cases of Primary Hypophysitis
Sun Mi Park, Ji Cheol Bae, Ji Young Joung, Yoon Young Cho, Tae Hun Kim, Sang-Man Jin, Sunghwan Suh, Kyu Yeon Hur, Kwang-Won Kim
Endocrinology and Metabolism.2014; 29(4): 470. CrossRef
Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
Won-Young Lee
Endocrinology and Metabolism.2014; 29(3): 251. CrossRef

A Case of Sheehan's Syndrome with Pancytopenia.: Hyun Suk Lee, Byung Woon Kwon, Jin Hyung Han, Hee Jin Kim; Endocrinol Metab. 2012;27(1):54-58. Published online March 1, 2012; DOI: https://doi.org/10.3803/EnM.2012.27.1.54

3,328 View
25 Download

Abstract PDF: Sheehan's syndrome is characterized by varying degrees of anterior pituitary dysfunction due to postpartum ischemic necrosis of the pituitary gland after massive bleeding. The spectrum of clinical presentation of Sheehan's syndrome is broad, with changes from nonspecific complaints, such as weakness, fatigue, and anemia, to severe pituitary insufficiency resulting in coma and death. Normochromic anemia is commonly associated with Sheehan's syndrome, but pancytopenia is rarely observed in patients with Sheehan's syndrome. We describe a 57-year-old woman with Sheehan's syndrome who presented with pancytopenia that was treated by hormone replacement with levothyroxine and glucocorticoid.

A Case of Pheochromocytoma Crisis with Acute Myocardial Infarction Induced by Glucocorticoids Administration.: Woo Sun Rou, Sang Kyung Jung, Sung Yun Lee, Yun Jeong Lee, Dong Jun Kim, Young Doo Kim, Hyung Yoon Kim, Sunhee Chang, Jung Hyun Noh; Endocrinol Metab. 2010;25(3):240-244. Published online September 1, 2010; DOI: https://doi.org/10.3803/EnM.2010.25.3.240

2,537 View
29 Download

Abstract PDF: The most common symptoms of pheochromocytoma are paroxysmal or sustained hypertension, or symptoms of paroxysmal adrenergic stimulation such as palpitation, headache, and diaphoresis. These patients can on rare occasion reveal or be complicated with cardiovascular symptoms such as arrhythmia, cardiomyopathy, acute coronary syndrome and cardiogenic shock. These cardiac manifestations of pheochromocytoma may delay the diagnosis, which can cause a catastrophic outcome. A pheochromocytoma crisis is provoked by surgery, anesthesia, exercise and, several drugs and it is known to be an endocrine emergency with mortality as high as 85%. Many classes of drugs are well known to precipitate adverse reactions, but the presentation of pheochromocytoma after the administration of steroid has rarely been reported. We report here on a case of pheochromocytoma crisis with acute myocardial infarction after the patient took prednisolone. Furthermore, we discuss the mechanism of glucocorticoid induced crisis and myocardial infarction in pheochromocytoma patients.

First
Prev
Page of 1
Next
Last

Search